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Introduction 1
1.    Introduction. 
 
The development of an organism from a fertilized egg into a multi-cellular organism 
starts with proper definition of the polarity. This polarity includes dorso-ventral, 
anterior-posterior and left-right symmetry. The embryological process is tightly 
regulated temporally and spatially and results from the interplay between several 
signalling pathways, which generate distinct signals defining the diverse array of cell 
types that make up an organism. Among the numerous pathways controlling this 
polarity the Transforming growth factor (TGF), delta-notch, retinoic acid and the 
Wnt/β-catenin (canonical Wnt signalling) pathways play crucial roles.  
The scope of this study focuses on the modulation of the Wnt/β-catenin signalling 
pathway, which regulates multiple aspects of mammalian development, and aberrant 
signalling through this pathway has been linked to human developmental disorders 
and diseases including cancer. Although much has been done to dissect this 
pathway, much is left unknown with respect to the different components of this 
pathway and how it is regulated in the developing embryo. The nuclear transducers 
of this pathway are the Lymphoid enhancer factors (Lefs) and the T-cell factors 
(Tcfs). They have been characterised to have different functions despite the fact that 
they all have almost identical binding partners. Moreover, structural data on Lef/Tcfs 
are restricted to the most conserved motifs and do not reveal differences between 
family members. The fact that there exist numerous Lef/Tcf splice variants and cross-
talks between the Wnt/β-catenin pathway and other signalling pathways further 
complicates the understanding of the regulation of individual Lef/Tcf-mediated signal 
transduction. The identification of sub type-specific Lef/Tcf binding partners and the 
different modes of regulation of these transcription factors remains an important cue 
to the understanding of this subtype specific activity.  
 
1.1    The Wnt/β-catenin or canonical Wnt signalling pathway 
 
In the simplest model of Wnt/β-catenin signal transduction, the binding of Wnt 
proteins to a frizzled transmembrane receptor inactivates the β-catenin degradation 
complex consisting of β-catenin, Axin, Adematous polyposis coli (APC) and glycogen 
synthase kinase (GSK)-3β. As a consequence, β-catenin accumulates in the 
cytoplasm, shuttles into the nucleus and together with the Lef/Tcfs activates Wnt/β-
catenin target genes. 
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This simple mode of activation is complicated by many components that modulate 
the activity of the pathway at each level of the signal transduction cascade (Fig1).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 1: The Wnt signalling pathway. Binding of Wnts to their transmembrane receptors 
Frizzled (Fz) and low density lipoprotein receptor-related protein (LRP) activates dishevelled 
(Dsh) following its phosphorylation by caseine kinases. Phosphorylated Dsh inactivates the β-
catenin degradation complex comprised of β-catenin, Axin, Adematous polyposis coli (APC) 
and glycogen synthase kinase (GSK)-3β. Accumulated cytosolic β-catenin shuttles into the 
nucleus and together with the Lef/Tcf family of transcription factors activate Wnt target 
genes. This pathway is regulated in the cytoplasm as well as in the nucleus by diverse proteins 
acting either as activators or repressors. In the absence of the Wnt signals β-catenin is primed 
by phosphorylation  and  targeted  by  β-transducin  repeat-containing  protein  (β-TrCP)  for 
degradation in the protesome. 
(http://www.infobiogen.fr/services/chromcancer/Deep/WNTSignPathID20042.htm). 
 
Extracellularly, the Wnts are inhibited by binding partners which mimic Wnt ligand 
receptors e.g. the secreted frizzled-related proteins (sFRP) (Moon et al., 1997) and 
Wnt-inhibitory factor (WIF)-1 (Hsieh et al., 1999). These proteins compete with Wnts 
for binding to frizzled thereby restricting Wnt signalling. At the level of the Wnt-
responsive ligand receptor interaction, Wnt proteins bind to the cysteine-rich domain 
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(CRD) of a seven transmembrane frizzled (fz) receptor (Bhanot et al., 1996). This 
binding is facilitated by a single-pass transmembrane molecule of the low density 
lipoprotein receptor-related protein (LRP) family (Lui et al., 2003). This stage is 
regulated by the inhibitor Dickkopf (Dkk) which forms a complex with and internalises 
LRP making it unavailable for Wnt reception  (Mao & Niehrs 2003). 
In the cytoplasm of the Wnt-responsive cell the pathway is regulated by kinases. 
Caseine kinase (CK)-1 and CK-2 activate Drosophila dishevelled (Dsh) or its 
vertebrate homologue, Dvl, by phosphorylation (Willert et al., 1997). In vertebrates, 
phosphorylated Dvl inhibits the activity of the β-catenin degradation complex. The 
result is the accumulation of cytosolic hypophosphorylated β-catenin which 
translocates into the nucleus and interacts with members of the Lef/Tcfs family of 
DNA-binding proteins leading to transactivation of Wnt target genes (Behrens et al., 
1996). In the nucleus, β-catenin converts the transcriptional repressive Tcf/Groucho 
complex into a transcriptional active Tcf/β-catenin complex. In the absence of Wnts, 
Axin recruits CK1 to the multiprotein complex causing priming of β-catenin and 
initiation of the β-catenin phosphorylation performed by GSK-3β. 
Hyperphosphorylated β-catenin is then recognized by β-transducin repeat-containing 
protein (β-TrCP) and degraded by the proteosome, reducing the level of cytosolic β-
catenin thereby inhibiting the Wnt/β-catenin pathway. 
The tight regulation of the Wnt/β-catenin pathway is absolutely necessary since it has 
been demonstrated to regulate numerous important developmental processes. 
Wnt/β-catenin signalling is involved in the induction of neural crest marker genes, 
Xslug and Xtwist, in Xenopus  (Chang et al., 1998), the renewal of neural crest stem 
cells (LaBonne et al., 1998) and the specification of cell fate in the adoption of a 
neuronal or pigmental phenotype by the neural crest cells (Dorsky et al., 1998). Wnt-
β-catenin signalling is also involved in body axis formation and mesoderm patterning. 
β-Catenin and other components of the Wnt/β-catenin pathway is essential for body 
axis formation in mice (Huelsken et al., 2000), Xenopus (Moon and Kimelman, 1998) 
and Zebrafish Solnica-Krezel, 1999). In Xenopus, accumulation of β-catenin on the 
dorso-anterior side of the embryo is the earliest sign of axis formation and precedes 
gastrulation (Larabell et al., 1997). Overexpression of β-catenin induces formation of 
an additional embryonic axis (Heasman et al., 1994). Interestingly, members of the 
Wnt-signalling cascade have are also involved in establishing the body axis in Hydra, 
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a member of the evolutionary ancient metazoan Phylum Cnidaria (Hobmayer et al., 
2000). These data suggest that Wnt signalling is a highly evolutionarily conserved 
process important for axial differentiation in the animal kingdom. This evolutionary 
conservation of Wnt/β-catenin signalling is also observed in the establishment of the 
dorsoventral polarity in the development of the chick limb buds (Kengaku et al., 
1998), mouse limbs (Parr et al., 2005) and segment polarity in Drosophila 
(Klingensmith et al., 1994).  
The need for tight regulation of the pathway is strengthened by the fact that aberrant 
signalling through this pathway has been linked to human developmental disorders 
and diseases including cancer. Mutation in the tumour suppressor adenomatous 
polyposis coli protein (APC) which is one of the components of the β-catenin 
degradation complex leads to accumulation of β-catenin, the root cause of colorectal 
cancer (Peifer, 1997). Moreover, mutations in β-catenin and Axin, all components of 
the pathway, have been found to be responsible for hepatocellular carcinoma 
(Taniguchi, 2002). 
 
1.2    Lef/Tcf transcription factors 
 
By virtue of their interaction with β-catenin, Lef/Tcf transcription factors are the 
nuclear transducers of an activated Wnt/β-catenin pathway. In vertebrates, there 
exist four family members: Tcf-1, Tcf-3, Tcf-4 and Lef-1. Generally, they are 
characterized by the presence of two highly conserved domains: the N-terminal β-
catenin-binding domain of about 60 amino acids and a high mobility group (HMG) 
box domain of about 80 amino acids. These two conserved domains sandwich a core 
domain comprised of an alternatively spliced activating Exon and two poorly-
characterised domains. (Fig. 2).  
The HMG box domain does not only mediate DNA binding to the consensus 
sequence (A/T)(A/T)CAA(A/T)GG of Wnt target genes (Clevers et al., 1997)  but also 
induces a sharp 120° bend in DNA to which it binds (Giese et al.,1995). Because of 
this bending ability and the observation that Tcfs can not directly activate 
transcription in reporter gene assays, it is proposed that Lef/Tcf family members 
serve an architectural function. Lef-1 appears unique in that it contains a context-
dependent activation domain (CAD) (Carlsson et al., 1993) which can activate 
transcription in the presence of the co-factor ALY (Bruhn et al, 1997). Flanking the 
conserved alternatively spliced Exon are two motifs that mediate repression of 
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transcription (Gradl et al., 2002a). This could be either by changing the overall 
structure of Lef/Tcfs so that transactivation via β-catenin can no longer take place or 
recruitment of a specific co-repressor by these motifs (Gradl et al, 2002a). Moreover 
the serine-rich motive SXXSS is subject to phosphorylation events that regulate 
DNA/protein interactions (Pukrop, et al., 2001). 
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Whereas the B- and the E-tails are predominant forms for hTcf-1 and hTcf-4, the B-
tail is the predominant isoform of hLef-1 (van de Wetering et al., 1996) (Fig. 3). This 
hLef-1B results from splicing which excludes exon XI of the C-terminus while splicing 
which includes this exon results to hLef-1N. (Hovanes et al., 2000). 
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The flanking regions of this alternatively spliced activating Exon comprise two 
different splice acceptor sites resulting to the presence or absence of an LVPQ and 
SFLSS motifs. These motifs are also differentially spliced in XTcf-4 giving XTcf-4A, 
4B and 4C. (Pukrop, et al., 2001) (Fig. 3). 
The conserved nature of some of the exons in Lef/Tcfs is remarkable (Fig. 4). Exon I 
codes for the β-catenin binding domain. In Lef-1 this exon is extremely large as it 
includes the entire 1.2 kb GC-rich 5´-untranslated region involved in post 
transcriptional regulation for proper translation of the Lef-1 coding sequences 
(Hovanes et al., 2000).  
 
Fig 4. Genomic organisation of hLef-1, hTcf-1 and hTcf-4 according to Duval et al., 2000 
and Hovanes et al., 2000. Possible translation start sites are indicated as arrows. The highly 
conserved β-catenin binding site is indicated in light grey boxes (extreme left). The exon VI 
of hLef-1 corresponds to Exon IVa in hTcf-1 and Exon VIII in hTcf-4. All other exons are 
indicated in bold. Dotted lines indicate splicing sites. (Gradl et al., 2002b). 
 
However, some splice variants of Lef-1, hTcf-1 and Tcf-4 have been found to lack 
this β-catenin binding domain and are regulated by alternative promoter usage 
(Hovanes et al., 2000). 
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Exon II-VI codes for parts of the poorly characterised context activation domain 
(CAD) domain in hLef-1. The CAD renders Lef-1 unique in activation of target genes 
without recruitment of the transcriptional activator, β-catenin. In all Lef/Tcfs the region 
corresponding to this CAD is less conserved. 
The Exons coding for the HMG box domain are very conserved. No naturally 
occurring Lef/Tcfs apart from Drosophila Tcf (dTcf) have the capacity to generate 
alternative DNA binding domains by splicing. This highly conserved gene structure 
points to a conservation in function (Dooijes et a., 1998).  In all Lef/Tcfs the HMG box 
domain is encoded by 3 exons. In humans these exons  are : VIII-X in Lef-1, VI-VIII in 
Tcf-1, X-XII in Tcf-4 (Hovanes et al., 2000). 
 
1.2.2    Lef/Tcfs Expression patterns and Function 
 
Considering the varied nature of developmental decisions regulated by Wnts one 
would expect a broad expression pattern of the nuclear transducers of the Wn/β-
catenin pathway. Surprisingly, Lef/Tcf expression patterns during embryonic 
development are quite often specific and restricted to distinct organs and regions. 
The expression of XLef-1 starts only after mid blastula transition (MBT) and at later 
stages, it is expressed in the central nervous system, eyes, otic vesicles, head 
mesenchyme, neural crest derivatives, brachial arches, developing heart, tail bud and 
limbs.  (Molenaar et al., 1998). In mammals Lef-1 mRNA is readily observed in pro- 
and pre- B-lymphocytes (Travis et al., 1991) and in all stages of T-lymphocyte 
differentiation. Although, mice generated to carry a homozygous germ-line mutation 
in the Lef-1 gene that eliminates its protein expression show no obvious defects in 
lymphoid cell populations at birth, they lack teeth, mammary glands, whiskers, hair 
and the mesencephalic nucleus of the trigeminal nerve, the only neural crest-derived 
neuronal populations. Together, the pattern of these defects suggests an essential 
role for Lef-1 in the formation of several organs and structures that require inductive 
tissue interactions (van Genderen et al., 1994). 
The expression of Tcf-1 is observed at high levels in the animal hemisphere in 
cleavage and blastula stage embryos. During gastrulation XTcf-1 is differentially 
expressed with high levels in the animal cap and all parts of the marginal zone except 
for a narrow domain around the blastopore. At neurula stages expression is 
predominant in the neural plate. At tail bud stages expression is localized in specific 
areas of the brain, in the eyes, the otic vesicle, branchial arches and head 
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mesenchyme, somites, tail bud, pronephros and pronephric duct (Roel et al., 2003). 
Tcf-1 expression has also been demonstrated in mice thymocytes. Although very low 
expression levels are found in the prothymocytes high level expression occurs from 
the prethymocyte stage onwards (Oosterwegel et al., 1993). Germline mutations in 
Tcf-1 have been found to block thymocyte development in mice at the transition from 
the cluster of differentiation (CD)8+ immature single-positive to the CD4+/CD8+ 
double-positive stage. Most of the immature single-positive cells in the mutants are 
not in the cell cycle and the number of immunocompetent T-cells in peripheral 
lymphoid organs is reduced. These observations confirm that Tcf-1 controls an 
essential step in thymocyte differentiation (Verbeek et al, 1995). 
Overlapping expression pattern of Tcf-1 and Lef-1 has been detected outside the 
lymphocytes in early mouse embryos. In neuroectodermal cell types (e.g. brain, 
neural crest) as well as in differentiating mesenchymal cells (e.g. in limb bud, 
pharyngeal arches, lung bud and urogenital system) (Oosterwegel et al., 1993). Tcf-1 
expression overlaps with that of Lef-1. The expression of the two genes is shut off 
around birth in these tissues, at the moment when the final architecture of most organ 
systems has been established. Tcf-1 and Lef-1 are thus thought to play a role in the 
establishment of organs rather than in the maintenance of a particular cell type 
(Oosterwegel et al, 1993). 
XTcf-3 is maternally expressed. Its expression pattern after MBT is very similar to 
that of XLef-1. It is expressed in the central nervous system, eyes, otic vesicles, head 
mesenchyme neural crest derivatives, branchial arches, developing heart, tail bud 
and in the limbs (Molenaar et al., 1998). Tcf-3 has been found to inhibit the induction 
the anterior/posterior axis in the mesoderm both in Xenopus (Molenaar et al., 1998) 
and in mice (Merrill et al., 2004).  
During embryogenesis, mTcf-4 displays a highly specific pattern of expression. It 
appears much later in development than do the other three family members, and its 
expression is essentially restricted to the di- and mesencephalon and the intestinal 
epithelium (Barker and Clevers, 2000). Disruption of the gene coding for Tcf-4 in 
mice results in death following birth. The neonatal epithelium is composed entirely of 
differentiated, non-dividing villus cells. Tcf-4 therefore is thought to control a genetic 
program that maintains the crypt stem cells of the small intestine (Korinek et al., 
1998). Although Tcf-4 is expressed in the mouse brain, brain defects have not been 
observed in Tcf-4 knockouts. In Xenopus, Tcf-4 has been found to demarcate the 
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forebrain-midbrain boundary (König et al., 2000). The expression of this transcription 
factor depends on Xwnt-2b, which is itself under the control of XTcf-4. This 
autoregulatory loop is indispensable for proper development of the midbrain and the 
isthmus (Kunz et al., 2004). 
As a summary, specific Wnt-driven patterning events are determined by the unique 
tissue distribution of different Tcf/Lef family members.  
Besides the unique role of the individual Lef/Tcfs in the development of different 
organs, double knockout experiments reveal functional redundancy of these 
transcription factors. Null mutations in both Lef-1 and Tcf-1 cause a severe defect in 
the differentiation of paraxial mesoderm and lead to the formation of additional neural 
tubes. These phenotypes are identical to those reported for Wnt-3a-deficient mice. In 
addition, Lef-1/Tcf-1 double knockout embryos have defects in the formation of the 
placenta and in the development of limb buds, which fail to express Fgf-8 and to form 
an apical ectodermal ridge. These observations provide evidence for a redundant 
role of Lef-1 and Tcf-1 in Wnt signalling during mouse development. (Galceran et al., 
1999). 
Tcf-4 and Tcf-1 also demonstrated functional redundancy. Tcf-4 and Tcf-1 double 
knockouts show severe caudal truncations with no hind limb and tail, duplications of 
the neural tube, defects in hindgut expansion, and an anterior transformation of the 
gastro-intestinal tract (transformation of the duodenum into the stomach) (Gregorieff 
et al., 2004). These data suggest that further Lef/Tcf double as well as triple knockout 
experiments may reveal further redundancy. 
 
1.2.3      Binding partners of the Lef/Tcf transcription factors 
1.2.3.1   β-catenin 
Since Lef/Tcfs have no intrinsic transactivation domain, apart from a context-
dependent transactivation domains in Lef-1 (Carlsson et al., 1993), Tcf proteins do 
not function as classical transcription factors. Sole binding of Lef/Tcfs to DNA is not 
sufficient to cause transcriptional activation (Eastman and Grosschedl, 1999). Instead 
they bind to a number of auxiliary proteins, thereby recruiting essential functional 
domains to the regulatory regions of target genes (Bruhn et al., 1997). Promoter 
activation is only achieved after complex formation with β-catenin to generate a 
functional bipartite transcription factor. Recent studies have revealed the mechanism 
by which this bipartite complex activates the promoter. In this complex, Lef/Tcfs 
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provide the DNA-binding moiety through their HMG box while β-catenin provides the 
transcription activation domain through its C-terminus (Barker and Clevers, 2000). 
The N-terminal domain of β-catenin comprised of approximately 130 amino acids 
contains putative GSK-3β binding sites which regulate its priming for ubiquitination 
(Dajani et al., 2001).  The central region of 12 imperfect repeats of 42 amino acids 
known as armadillo repeats (since they show homology with repeats found in the Arm 
protein of Drosophila) mediate binding to Lef/Tcfs. These armadillo repeats are 
arranged to form a super helix of 12 repeats with each repeat (except repeat 7) 
comprised of 3 helices (Fig. 5).   
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 5:  The overall structure of the XTcf-3-β-catenin binding domain/β-catenin armadillo 
repeat complex. Two views of the complex are related by a 180° rotation about the β-catenin 
super helical axis. The armadillo repeat of β-catenin forms a super helix made up of 12 
repeats. Each repeat, except repeat 7, consists of 3 helices (shown in blue, green and yellow) 
respectively. The β-catenin binding domain of XTcf-3 is shown in red and consists of (from 
N- to C-terminus) a β hairpin module, an extended region that contains β-strand and an α-
helix. Unresolved structures are shown in dashed lines. The β-catenin binding domain of 
XTcf-3 wraps around the armadillo repeat region of β-catenin in an anti parallel fashion along 
the major axis of the super helix (Graham et al., 2000). 
 
Through their β-catenin binding domain (CBD), each Lef/Tcf forms an elongated 
structure that runs anti parallel along the major axis of the positively-charged (Lysine-
rich) groove of the super helix. The CBD mediates physical interactions with the 
super helix in three ways: through the acidic N-terminal β-hair pin domain, the central 
β-strand and the C-terminal α-helix. 
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The function of this complex is tightly regulated by a multitude of binding partners 
which either co-activate or co-repress gene transcription. The functions of these 
binding partners are discussed in detail in the following.  
 
1.2.3.2      Co-activators of the Lef/Tcfs 
The co-activators of the Lef/Tcfs include a variety of proteins involved in either 
chromatin modelling, activation through the HMG box or activation of the Lef/Tcfs in 
an unusual way.  
As co-activators involved in the modelling of the chromatin are the cyclic AMP 
receptor-binding (CREB) protein (CBP). In Wnt-stimulated Xenopus cells, the 
transactivating domain of β-catenin interacts with CBP and this synergistically 
stimulate transcription of Wnt target genes (Takemaru and Moon, 2000) (Fig. 6).  
 
NLK 
CBP 
ß- catenin 
CK1ε 
      Groucho 
SR
PIAS 
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c-Jun 
CtBP 
Smad 
 
 
 
 
 
 
 
Fig 6: Lef/Tcf function is regulated by a multitude of binding partners: β-catenin furnishes 
the activation domain, the CREB-binding proteins (CBP) favour an open chromatin structure, 
the smads bind to HMG-box while the Caseine kinases (CK1ε) phosphorylate the β-catenin 
binding site. Groucho, C-terminal binding protein (CtBP) favour a closed chromatin structure, 
the HMG box-containing protein-1 (HBP1), Protein inhibitors of activated STAT1 (PIAS), 
Steroid receptors (SR) mask the HMG box,. ALY specifically binds to both the HMG box and 
core region of Lef-1. (http://www.stanford.edu/~rnusse/pathways/binding.html). 
 
CPBs are histone acetylases and are thought to acetylate nucleosomal histones 
resulting to a more open conformation of the DNA. This allows the transcription 
machinery to gain access to the promoter region to initiate transcription (Goodman 
and Smolik, 2000). The enhancing effect of CBP on the transcriptional potential of β-
catenin-bound Lef/Tcfs is however limited. Only a modest increase in transcriptional 
level is observed indicating that they might act in concert with more factors to achieve 
efficient gene activation.  
The smads have been found to enhance this complex in transactivation by binding to 
the HMG box (Fig. 6). Smads are the nuclear transducers of the transforming growth 
factor (TGF)-β signalling pathway. They are comprised of highly conserved Mad 
homology (MH) N-terminal and C-terminal domains (referred to as MH1 and MH2 
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domains respectively) separated by a less conserved linker domain (Heldin et al., 
1997). It has been reported that through these MH1 and MH2 domains smads 
interact with the HMG domain of Lef/Tcfs to synergistically activate the Xenopus 
homeobox gene, twin (Labbé et al., 2000, Nishita et al., 2000). Moreover smads 
recruit transcriptional co-activators such as P300 and CBP to target promoters and 
may provide a transactivation domain to transcription factors (Derynck et al., 1998).  
The ubiquitously expressed nuclear protein ALY has also been shown to interact with 
the core region and the HMG box of Lef-1 (Fig.6).  Although nothing as yet indicates 
that ALY is involved in the Wnt/β-catenin pathway, the complex Lef-1/ALY together 
with acute myeloid leukaemia (AML) factor-1 activate enhancers of specific target 
genes, such as the T-cell receptor- enhancer (TCR). This association increases the 
affinity for both Lef-1 and AML proteins to bind DNA. ALY therefore mediates 
transcriptional activation by facilitating the functional collaboration of multiple proteins 
in the TCR alpha enhancer complex (Bruhn et al., 1997).  
An unusual way of regulating Tcf-3 is observed in its activation by casein kinase 
(CK)1ε. With the evidence that a substantial amount of Tcf-3 is extra-nuclear (Lee et 
al., 2001) its activity is enhanced by binding to CK1ε. This kinase phosphorylates 
XTcf-3 at conserved phosphorylation sites in the β-catenin-binding region (Fig. 6). 
The outcome of this phosphorylation is the increase in affinity of Tcf-3 for cytoplasmic 
β-catenin. Phosphorylated Tcf-3 therefore competes with Axin and APC for binding to 
β-catenin resulting to decreased degradation of β-catenin. These phosphorylation 
sites are also present in other members of the Lef/Tcf family suggesting that similar 
phosphorylation procedures might take place to enhance β-catenin binding (Lee et 
al., 2001). 
Another more specific phosphorylation dependent regulation of Tcfs is observed in 
intestinal cancer. The binding of Tcf-4 to the proto-oncoprotein, c-Jun, is only 
possible following phosphorylation of the of c-Jun protein by c-Jun N-terminal kinases 
(JNK). Phosphorylated c-Jun then interacts with Tcf-4/β-catenin complex. This 
interaction is mediated via the HMG box of Tcf-4 and the conserved serines 63 and 
73 of c-Jun. The complex Tcf4/β-catenin/c-Jun regulates transcription of c-jun gene 
favouring intestinal cancer progression (Nateri et al., 2005). 
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1.2.3.3     Co-repressors of Lef/Tcfs 
 
Numerous experiments have shown that Lef/Tcfs do not only function as 
transactivators when activated by Wnt/β-catenin signalling. They can either actively 
associate with co-repressors to inhibit target gene expression in the absence of 
Wnt/β-catenin signalling or bind to other partners to modulate other signalling 
pathways. 
Among the co-repressors are proteins altering the chromatin structure, some mask 
the conserved domains and others inhibit the Lef/Tcf function in an unusual manner. 
In the list of co-repressors of Lef/Tcfs that alter the chromatin structure are the 
Drosophila Groucho and their human homologues, transducin-like enhancer of split 
(TLE)1-4 proteins and the C-terminal binding proteins (CtBP). The Grouchos are 
general transcriptional repressors of the Lef/Tcfs. These proteins are characterized 
by a conserved C-terminal WD-repeat domain which mediates interactions with DNA-
bound Lef/Tcfs (Brantjes et al., 2002). The interaction domain in the Lef/Tcfs is the 
core region comprised between the β-catenin binding site and the HMG box. It is 
believed that Groucho family proteins repress transcription through their 
glycine/proline-rich variable region which recruits histone deacetylase Rpd-3 to the 
template. These enzymes are known for their function as silencers of transcription by 
altering local chromatin structure (Chen and Courey, 2000). Although Groucho and β-
catenin have different binding sites they compete for binding to Lef/Tcfs (Daniels and 
Weiss, 2005). In the absence of a Wnt/β-catenin signal, Tcf/Groucho complexes act 
as repressors of gene transcription. Upon activation by Wnt signals, β-catenin 
replaces Groucho and thus results into a complex that activates transcription of Wnt 
target genes. The almost ubiquitous expression pattern in Xenopus (Ishitani et al., 
1999) coupled with the fact that Grouchos bind indiscriminately to Lef/Tcfs suggest 
that these proteins might not contribute to the functional  diversity of Lef/Tcfs.  
Unlike the Grouchos, CtBP acts as a co repressor only to a subset of Tcfs. It binds 
only to XTcf-3 (Brannon et al., 1999) and to one of the splice variants of hTcf-4 (Tcf-
4E) (Valenta et al., 2003). This interaction is mediated by the PLSLV/T motif located 
in the C-terminal of both transcription factors. These sites have also been found in 
hTcf-3 and hTcf-1E but their functional interaction has not yet been confirmed. CtBP 
acts as a histone deacetylase resulting in a closed chromatin structure thereby 
inhibiting the transcriptional machinery (Valenta et al., 2003). The fact that this co-
repressor binds only to a subset of Tcfs suggests its role in defining differences in 
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Lef/Tcf target gene activation. However elimination of the C-terminus of XTcf-3 and 
thus CtBP binding, has not been found to have any effect on the inhibitory character 
of XTcf-3 (Gradl et al., 2002a). This suggests that additional repressive motifs might 
exist in XTcf-3.  
Another mode of repression is to binding and mask the HMG box. This is observed in 
the regulation of the promoters c-myc and cycline D1. These genes are responsible 
for malignant proliferation following inappropriate activation of Wnt/β-catenin 
pathway. The HMG-box-containing protein-1 (HBP1) is described as an ubiquitously 
expressed protein that binds to the Lef/Tcfs through its repressive domain (aa220-
aa401). Unexpectedly, this interaction is not mediated by competition with Lef/Tcfs for 
binding to target DNA but by direct binding to the HMG box of Lef/Tcfs (Sampson et 
al., 2001). Also, HBP1 shows no preference to any Lef/Tcf subtype indicating that it 
might be a general Lef/Tcf repressor and can not contribute to the functional 
specificity observed in Lef/Tcfs. 
A second regulatory mechanism through masking of the HMG box is by sumolylation 
and subsequent sequestration into subnuclear structures. Inhibitors of signal 
transducers and activators of transcription (STAT1) have been found to bind to Lef-1 
and repress its transcriptional activation potential by sequestration. A candidate 
inhibitor of STAT1 is PIAS1 (Protein inhibitor of activated STAT1) (Chung et al., 
1997). PIAS1 binds to the HMG domain of Lef-1 and acts by conjugating lysine 
residues of Lef-1 with the small ubiquitin-like modifier 1 (SUMO1) protein. This 
sumoylation targets Lef-1 to nuclear bodies where it is sequested thereby 
antagonizing Wnt-induced transcriptional activation (Sachdev et al., 2001).  
Although the CBP has been found to be a co activator of the Wnt target genes in 
Wnt-stimulated cells, it acts as a co-repressors in unstimulated cells. In Drosophila, it 
has been found to acetylate a conserved lysine (Lys 25) in the β-catenin-binding 
domain in Drosophila Tcf (dTcf) thereby reducing dTcf affinity for armadillo 
(Drosophila homologue of β-catenin). It is speculated that in this case CBP serves as 
a negative control mechanism to keep Tcfs passive and therefore eliminates 
inappropriate activation of Tcfs (Waltzer and Bienz, 1998). 
Phosphorylation-dependent binding of proteins to Lef/Tcf is a further unusual type of 
repression. The Nemo-like kinase (NLK) has been shown to interact directly with 
Lef/Tcfs. This interaction induces phosphorylation of Lef/Tcfs on two conserved 
Introduction 16
serine/threonine residues in the core domain thereby, reducing the affinity of the β-
catenin/Lef/Tcf complex to bind DNA (Ishitani et al., 2003).  
 
1.3.      Integration of the The Wnt/β-catenin signalling pathway into a cross- 
            regulatory network. 
 
Some of the binding proteins of nuclear β-catenin and Lef/Tcfs do not only modulate 
the response of cells to Wnt/β-catenin signalling but also comprise adaptor proteins 
through which the Wnt/β-catenin pathway cross-talks with other signalling pathways 
in numerous developmental processes .  
As examples for such cross-talks, the smads bridge Wnt/β-catenin signalling to 
TGFβ- signalling at many levels. Through smad-2 the activin/Vg-1 of the TFG-β 
cooperates with the Wnt/β-catenin pathway to induce Wnt/β-catenin target genes 
(siamois and Xnr3) (Crease et al., 1998). Reciprocally, and still through smad-2, the 
Wnt/β-catenin pathway enhances the induction of TGF-β target genes (goosecoid 
and chordin) (Crease et al., 1998). Moreover, the existence of Wnt- and TGF-
responsive elements in the Xgoosecoid promoter suggests that Wnt signals may 
provide a cooperative stimulus for the induction of genes responsive to the 
activin/Vg-1 signalling (Watabe et al., 1995).  
Activin/Vg-1 signalling pathway has been demonstrated in the vegetal cell of the pre-
gastrula embryo and in the presumptive mesoderm (Weeks et al., 1987) while the 
Wnt/β-catenin signalling pathway is present at the dorsal side of the embryo (Wylie et 
al., 1996). The two pathways overlap in the dorsal vegetal domain of the embryo 
which corresponds to the domain in which genes of the Spermann organiser 
(siamois, Xnr3, goosecoid and chordin) are induced (Fig. 7). Since the Spermann 
organiser has been found to induce the primary body axis the cooperation between 
these pathways could impart a fine level of patterning information across the early 
organiser domain (Crease et al., 1998).   
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Fig. 7: Cross-talk between Wnt/ß-catenin signalling and transforming growth factor 
(TGF)-β  pathway. Wnt/β-catenin signalling pathway at the dorsal side of the embryo cross-
talk with the activin/Vg-1 signalling through smad-2 at the vegetal pole to induce the 
Spermann organiser at the dorsal vegetal pole. (Crease et al., 1998). 
 
An alternative TGF-β pathway that modulates the Wnt/β-catenin pathway is the 
mitogen-activated protein (MAP) kinase pathway.  This pathway activates the Nemo-
like kinase (NLK) via TGF-β activated kinase (TAK)-1. NLK has been found to directly 
phosphorylate and inactivate the Lef/Tcf transcription factors (Ishitani et al., 2003). 
The consequence of this inhibition is the down-regulation of Lef/Tcf target gene 
expression. 
Cooperation with other pathways also occurs following direct binding to transcription 
factors. The direct binding of smads to Lef/Tcfs relates the bone morphogenic protein 
(BMP) pathway (another TGF-β pathway) to the Wnt/β-catenin pathway and plays an 
important role in the control of critical developmental processes. In Xenopus, the 
collaboration between these pathways directly and synergistically affects expression 
of the twin gene during establishment of the Spermann organizer. This Interaction 
thus permits tight control in the specification dorsal axis. (Labbé, 2000, Nishita et al., 
2000). 
The collaboration between the Wnt/β-catenin signalling and the TGF-β signalling is 
not always synergistic. It is also antagonistic in the control of developmental 
processes. Through smad/Lef/Tcf interaction for example, the Wnt/β-catenin pathway 
inhibits the expression of bone morphogenic protein (BMP)-4 at the dorsal side of the 
early Xenopus embryo during neural development (Backer et al., 1999). This 
inhibition is a regulatory step in the induction of the primary body axis in Xenopus. 
Reciprocally, it is shown in mice that through phosphorylated smad-1, -5, -8, the 
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PTEN/Akt pathway inhibits the Wnt/β-catenin pathway by limiting nuclear 
translocation of β-catenin. The consequence is the inhibition of Wnt/β-catenin-
induced intestinal stem cell self-renewal (He et al., 2004). All these observations 
points to a complex regulatory network of cross-regulation between TGF-β and 
Wnt/β-catenin pathways in the control of developmental processes (Fig. 8). 
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Fig. 8: Many signalling pathways converge at or diverge from the Wnt/β-catenin signalling 
cascade thereby establishing a cross-regulatory network. Delta/Notch pathway enhances the 
Lef/Tcf-driven transcription through interaction with β-catenin. p53, through a negative 
feedback process down-regulates β-catenin levels while β-catenin also down-regulates p53 
levels. Steroid signalling establishes cross-talks with the Wnt/β-catenin signalling through 
steroid receptors (SR). The TGF-β signalling regulates Lef/Tcf driven transcription either 
through smads or through the Nemo-like Kinase (NLK) of mitogen-activated protein kinase 
(MAPK)  
 
Further regulatory network modulating the Wnt/β-catenin signalling cascade is 
established through the interaction with the Delta/Notch signalling pathway. Wnt-
responsive transcription factors of the Lef-1/Tcf family are involved in a direct 
regulation of the Delta-like1 (Dll1) gene of the Notch signalling pathway, thus 
providing a molecular link between the Wnt /β-catenin and the Notch signalling 
pathway in somitogenesis (Galceran et al., 2004). Also, Notch has been found to 
directly bind through its N-terminal tail to the active form of β-catenin thereby 
regulating β-catenin levels (Fig. 8). This modulation provides two functions: it 
establishes a threshold for Wnt/β-catenin signalling that is likely to play an important 
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role in the patterning of tissues and the assignation of cell fates during development 
(Martinez et al., 2002) and, in addition it provides a stringent regulation of the 
activated form of β-catenin. The second function might be crucial in pathological 
situations and might contribute to the understanding of Notch as a tumour suppressor 
(Radtke and Raj, 2003). 
One important cross-talk demonstrates a negative feedback process between β-
catenin and p53. Excess of β-catenin induces accumulation of active p53 (Damala et 
al., 1999). Reciprocally, activated p53 down-regulates β-catenin thereby 
counteracting oncogenic effects (Sadot et al., 2001) (Fig. 8). Disruption of this 
feedback process affects tumorigenesis driven by deregulated β-catenin activity. The 
high frequency of p53 inactivation observed in colorectal cancer (Peifer, 1997) and 
hepatocellular carcinoma (Taniguchi et al., 2002) underlies the significance of the 
mutual control mechanism. The fact that hTcf-4 is a direct downstream target of p53 
(Rother et al., 2004) further supports the cross-regulatory mechanism (Fig. 8).  
The binding of β-catenin and Lef/Tcfs to steroid receptors establishes a link between 
Wnt/β-catenin signalling to steroid signalling. A mechanism by which Wnt/β-catenin 
signals may regulate expression of a subset of androgen receptor (AR)-regulated 
genes during male development and in prostate cancer has been reported. This is 
mediated through a cooperative binding interaction between AR and Tcf-4 on 
regulatory elements of these genes. The AR/Tcf-4 complex serves as a potent 
transcriptional repressor in resting cells but is a very sensitive target for β-catenin 
signalling (Amir et al., 2003). Interaction between estrogen receptors (ER), Tcf-1, and 
Tcf-4 has also been reported. Whereas Tcf-4 antagonises ER activity in rat mammary 
cells Tcf-1 activity is synergistic. As Tcf-4 being the most prominent Tcf family 
member in the breast, it is suggested that in vivo, the antagonistic interaction is 
dominant in this tissue (El Tanini et al., 2001).  
Reciprocally, steroid receptors have also been found to regulate the Wnt/β-catenin 
pathway. Competition between glucocorticoid repressors (GR) and Tcfs for β-catenin 
binding (Song et al., 2003) leads to repression of the Wnt/β-catenin pathway. This 
cross-talk is further emphasised by glucocorticoids which suppress Wnt/β-catenin 
signalling by inhibition of phosphorylalation of glycogen synthase kinase (GSK)-3β 
(Smith and Frankel, 2005) or by the enhancement of dickkopf-1 production in 
osteoblasts (Ohnaka et al., 2005). 
Introduction 20
In summary, the establishment and stability of cell fates during development depend 
on the integration of multiple signalling pathways. Whereas some of these pathways 
are synergistic, others antagonise each other. This makes it very important to search 
for binding partners that bridge the different pathways to Wnt/β-catenin signalling. 
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2.    Aim of this Study. 
 
The individual Lef/Tcf transcription factors have specific biological functions. This 
functional diversity is not explained by the known binding partners they recruit. Many 
of the known binding partners are not specific to any Lef/Tcf subtype. The hypothesis 
of this work is that since tissues are capable of responding to Lef/Tcf-mediated 
signals in a subtype-specific manner, then less conserved motifs within this family of 
transcription factors might act by recruiting different co-factors and this might be at 
the origin of their functional diversity. A candidate region for recruitment of these co-
factors is the core region comprised between the β-catenin binding site and the HMG 
box. This core region is less conserved in the Lef/Tcf family of transcription factors 
and might render each family members unique in its function through recruitment of 
different co-factors.  
The aim of this work is therefore to identify and characterize proteins that bind 
specifically to this core region of Lef/Tcfs and provide individual family members with 
specific characteristics. Because Wnt/β-catenin signalling is embedded in a complex 
regulatory network, identified proteins will be investigated for their role as adaptor 
proteins in the communication with other signalling pathways. 
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3.   Materials.  
 
Antibiotics: 
- Ampicillin Na-salt                   (Serva, Heidelberg)  
- Kanamycine                           (Amplichem, Darmstadt)               
- Penicillin/Streptomycin          (Invitrogen) 
-Tetracycline                            (Sigma-Aldrich Chemie GmbH, Steinheim) 
 
Antibodies: 
- Anti Myc primary antibodies  (Cell culture, Zoology Institute II) 
- Goat anti mouse peroxidase secondary antibodies (Dianova, Dörentrup) 
- Anti Lef-1                              (Dinova) 
- Anti Tcf-3 /-4                         (Dinova) 
- Anti Hic-5                              (BD Biosciences) 
 
Bacterial strains:  
- Bl21 DE3 strain:  BL21 (DE3)hsdS gal (cIts857 ind1 Sam7 nin5 lacUV5-T7gene1)      
(Promega GmbH, Manheim) 
- JM109 strain: endA1 recA1 gyrA96 thi hsdR17(rk-,mk+) relA1 supE44 I-D (lac-
proAB) [F' traD36 proAB laqIqZDM15]. (Promega GmbH, Manheim) 
- XL1-Blue MRF˘strain: D(mcrA)183 D(mcrCB-hsdSMR-mrr)173 endA1 supE44 thi-1 
recA1 gyrA96 relA1 lac [F˘proAB lacIqZDM15 Tn10 (Tetr)]. (Stratagene)   
 
Kits: 
- ECL + Western Blotting Detection system             (Amersham GmbH, Freiburg) 
- pGEMR-T Easy Vector System                               (Promega GmbH, Manheim) 
- QIAGENR Plasmid Midi Kit                                     (Qiagen GmbH, Hilden) 
- QIAprepR Spin Miniprep Kit                                    (Qiagen GmbH, Hilden) 
- QIAquickR Gel Extraction Kit                                  (Qiagen GmbH, Hilden) 
- Random primed DNA labelling kit                          (Boerhringer, GmbH, Manheim) 
- TNTR SP6 Coupled Reticulosite Lysate System    (Promega GmbH, Manheim) 
- TNTR T7 Coupled Reticulosite Lysate System       (Promega GmbH, Manheim) 
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Chemicals: 
Unles otherwise stated, all chemicals were of molecular biology grade and from 
Amplichem GmbH, (Darmstadt), Roth GmbH (Karlsruhe), Fluka Chemie GmBh 
(Taufkirchen), Merck GgaA (Darmstadt), Sigma Aldrich Chemie GmbH (Taufkirchen). 
 
- Agarose                                                         (Invitrogen GmbH, Karlsruhe) 
- Ammoniumpersulfate                                  (Bio-Rad Laboratories GmbH, München) 
- Bactotryptone                                                (Invitrogen GmbH, Karlsruhe) 
-Complete, Mini, EDTA-free  
 protease Inhibitor cocktail tablets                   (Roche Diagnostics, Mannheim) 
- [α32P]dCTP                                                    (Amersham GmbH, Freiburg) 
- 100bp DNA ladder Molecular weight marker (New England Biolabs, Frankfurt a. m.) 
- 2-log DNA Molecular weight marker              (New England Biolabs, Frankfurt a. m.) 
- 35S-methionine                                               (Amersham GmbH, Freiburg) 
- Deoxyribonucleoside triphosphates (dNTPs)(Promega GmbH, Manheim) 
- Dithiotritol (DTT)                                            (Invitrogen GmbH, Karlsruhe) 
- Dulbecco´s modified eagle´s medium           (DMEM) (BioWhittakerTM Belgium). 
- Fetal Calf serum                                            (Invitrogen GmbH, Karlsruhe) 
- Glass beads (425-600µm)                (Sigma-Aldrich Chemie GmbH, Steinheim) 
- Glutathione (GHS) sepharose 4B                 (Amersham GmbH, Freiburg) 
- Nickel nitrilo triacetic acid (NTA)-agarose     (Qiagen GmbH, Hilden) 
- Phenol                                                           (Promega GmbH, Manheim) 
- RnasinR ribonuclease inhibitor                      (Promega, gmbH, Manheim) 
- Select agar                                                    (Invitrogen GmbH, Karlsruhe) 
- Sephadex G50 spin columns                        (Amersham GmbH, Freiburg) 
- Sodium deodecyl sulfate (SDS)                    (Serva Electrophoresis, Heidelberg) 
- Tripsin / EDTA                                               (Invitrogen GmbH, Karlsruhe) 
- Tween-20                                                      (Serva, Heidelberg) 
- Yeast extract                                                 (USB Cleveland, USA) 
 
Enzymes:  
- Advantage polymerase                                (Clontech, Heidelberg) 
- Dnase I Rnase-free                                      (Roche Diagnostics GmbH, Manheim) 
- Klenow                                                         (Promega GmbH Manheim) 
- Rnase A                                                       (Amplichem, Darmstadt) 
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- Shrimp alkaline phospatase (SAP)              (Promega GmbH, Manheim) 
- T4 DNA ligase                                              (Promega GmbH, Manheim) 
- Reverse transcriptase                                  (Gibco BRL GMBH, Karlsruhe)                    
 
Constructs: 
 
- For subcloning in bacterial expression vectors: 
-pET41b from D.  Gradl (karlsruhe) 
-pETM-30 from G. Stier (Heidelberg) 
.pGex-Hic-5 from from M. Stallcup (South Callifornia)   
 
- For eukaryotic cell transfection: 
- Androgen receptor in pSG5 from  A. Cato (Karlsruhe) 
- Cytomegalovirus (CMV)-β- galactosidase from D. Gradl (Karlsruhe) 
 - mhic-5 in  PSG5 from C. Chang (New York) 
- mMBP1in pcDNA3.1 from W. M. Gallagher (Dublin)  
- MMTV Luciferase reporter  from Olver Kassel (Karlsruhe)  
- TopFlash promoter from J. Hollander (Basel) 
- Xfibronectin reporter in from D. Gradl (Karlsruhe) 
 
- For Invitro transation: 
                                                                                 Polymerase used for translation  
mLef-1 in pSP64T3 from J. Behrens (Erlangen, Germany)                      T7 
hTcf-3, hTcf-4, mTcf-3, hTcf-1in pcDNA3  from W. Birchmeier (Berlin)    T7 
XLef-1, XTcf-3, XTcf-4  in pCS2-Myc (D. Gradl)                                      SP6 
TOLLIP in pcDNA3.1 from S. Ghosh (Yale, USA)                                     T7         
DLXIN-HA in pcDNA from S. Kani (Japan)                                                T7 
ARC-105 pDH105  from Y. Kato (Tallahassee, USA)                               SP6 
ROR2-HA in pcDNA from S. Kani (Japan)                                                 T7 
RNF-4 in pcDNA3 from K.A Engelka ( Philadelphia, USA)                        T7 
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Equipment  : 
 
- Blot apparatus, Mini transblot                         (Bio-Rad, München) 
- Centrifuges: 
 Biofuge fresco                                         (Kendo, Langenselbold) 
 MultifugeR 3S-R                                      (Kendo, Langenselbold) 
- Gel documentation: 
    DIANA II                                                  (Raytest, Straubenhardt) 
    Gel Max                                                   (Intras, Göttingen) 
-Fluorecence binoculars: 
 MZFLII                                                    (Leica Microsystem, Bensheim) 
 Digital Camera Retiga Color 12 bit         (QImaging, Burnaby, Kanada) 
  Software, Openlab 3.1.2                         (Openlab, Heidelberg)            
-Fluorecence microscope: 
 DMIRE2 and CTR MIC                           (Leica Microsystem, Bensheim) 
 Digital Camera C4742-95-12 ERG         (Hamamatsu, Heidelberg) 
 Software, Openlab 3.1.2                         (Openlab, Heidelberg) 
- Hybridisation incubator 7601                           (GFL, Burgwedel) 
- Incubator shaker, orbital shaker                      (Thermo Forma, Marietta, USA) 
- Luminometer, Lumat LB 9507                   (Berthold Technologies, Bad Wilbad) 
- PAGE apparatus, Mini Protean IITM                 (Bio-Rad, München) 
- PCR cycler, Personal cycler and UNO II         (Biometra , Göttengen) 
- pH meter pH 521                                             (WTW, Weilheim) 
- Phosphoimager BAS 1500                              (Fuji, Japan) 
- Sonifier: UW2070                                            (Bandelin electronic, Berlin) 
- Spectrophotometer, Bio-photometer               (Eppendorf, Hamburg) 
- Spectrophotometer, Ultraspec 2100 pro         ( Amersham,  Freiburg) 
- Water bath: Victor Recker                               (Krankenhaus-laborbedarf, Berlin) 
- Weighing balances, LC2201P and  ISO9001 (Satorius) 
- Micropipette puller                                           (Sautter Instruments, Novato, USA) 
 
 
 
 
 
Materials 26
Primers: 
 
All primers were synthesised by either biomers.net GmbH (Ulm) or BD Bioscience 
(Heidelberg). 
 
-For cloning into BTM 116 vector : 
Xlef1BamHIFwd:               5´-ATAGGATCCTTAATGAGACTGAGATTATCCCC-3´  
Xlef1PstIRev :                   5´-ATACTGCAGAGGTTTCTTTATGTGAGG-3´ 
  XTCF3EcoRIFwd:                5´-ATAGAATTCTCAGAGGTGGAGAGGCGTCCC-3` 
      HMGBack3,4SalI:             5´-ATAGTCGACYAGDGGYTTCTTWATGTGVGG-3´                                  
       XTCF4A,B,C.EcoRIFwd:  5´-ATAGAATTCTCCGAGACCGAGCGGCG-3         
       HMGBack3,4SalI:             5´-ATAGAATTCTCCGAGACCGAGCGGCGACCCCCC-3` 
                                                      
-For cloning into pETM-30 expression vector: 
Lef-1Nco1forw:                  5´-TATGCCATGGAGACTGAGATTATCCCC-3´  
TCF-3Nco1forw:                5´-TATGCCATGGAGGTGGAGAGGCGTCCC-3´                                        
TCF-4NCbluntforw:           5´- GAG ACC GAG CGG CGA CCC-3´  
HMGBACK2:                     5´- ATA CTC GAG YAG DGG YTT CTTWAT GTG VGG-3´ 
    HicLDNco1Fwd:                5´- TCACCCATGGGTTAGG-3´ 
     HicLDXho1Rev:                5´- ATATCTCGAGGTGTGG-3´ 
     HicLimNco1Fwd:               5´- GGCGCCATGGTAAACC-3´ 
     HicLimXho1Rev:               5´- ATATCTCGAGTTCAGG-3´ 
 
- For cloning into PCS2-myc vector: 
mHicXhoIIStart:         5´- CGTCTCGAGCACATGTCACGGTTAGGGGC-3` 
mHicXhoI:IStop:                5´- CGACTCGAGTCACGCGAAGAGCTTCAGG-3` 
mBP1XhoIFwd:                 5´- ATATACTCGAGATGCTCCCTTTTGCC-3` 
mMBP1XhoI Rev:             5´- TATATCTCGAGGAAGGTATAGGCTCC-3` 
XHicNcoIstart:                   5´- ATATCCATGGTAATGTCGAATACGACG-3` 
XhicXhoIStop:                   5´- TATACTCGAGCTACCCATACAGTCGGG-3` 
 
-For sequencing clones in pVP16 vector: 
pVP16 Fwd:                      5´-GGT ACC GAG CTC AAT TGC GG-3` 
pVP16 Rev:                      5´-AGC TAG CTT CTA TCT ATC TAG CG -3´ 
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Libraries: 
 
-Mouse Day 10 cDNA library. 
The library screened was kindly provided by Jürgen Behrens. The library constructed 
is in the NotI site of pVP16 vector and in frame with the VP16 protein (AD). The 
plasmid carries an ampicillin-resistance gene for antibiotic selection and a leucine 
gene for growth selection in cultured media. It also has an NLS that allows for nuclear 
targeting of the hybrid protein.  
  
-Xenopus Tad pole stage λ-zap cDNA library. 
This was kindly provided by Michael Kühl (Ulm).  
 
Solutions: 
 
- Bacteria Culture Media: 
LB-Agar: 
1.5% Agar in LB medium. Autoclave at 120 °C for 20 min. 
LB medium: 
10g Bactotryptone, 5g yeast extract, 10g NaCl, add water to 1l. Autoclave at 
121°C, 20 min. Store at +4°C. 
SOB medium: 
20g Bactotryptone, 5g yeast extract, 0.5g NaCl, 2.5g MgCl2.6H20, add distilled 
water to 1l. Autoclave at 121°C, 20 min. Store at +4°C. 
2YT-agar: 
2YT medium, 1.5% agar. 
2YT medium: 
16g tryptone, 10g yeast extract, 5g NaCl. Autoclave at 121°C, 20 min. Store at +4°C.  
- Bacteria Transformation Media: 
TFB1                                    
30 mM potassium acetate, 10mM CaCl2, 50mM MnCl2, 100mM RbCl, 15% 
Glycerol, adjust pH to 5.8 with acetic acid. Filter-sterilize (0.2 µm).            
TFB2 
100 mM MOPS, 75mM CaCl2, 10mM RbCl, 15% Glycerol, adjust pH to 6.5 
with 1M KOH, Filter-sterilize (0.2 µm).   
- DNA Analysis Buffers: 
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TAE:  
40 mM Tris/acetate, pH 8.3, 1mM EDTA. 
TE buffer: 
  10 mM Tris-Cl, pH 7.5 1 mM EDTA. 
 
- Phage library Screen Media: 
Denaturing solution: 
0.5 M NaOH, 1.5 M NaCl. 
Hybridisation solution: 
6x SSC, 5x Denhardt´s solution, 1% SDS, 100µg/ml Salmon sperm DNA. 
Neutralisation solution: 
0.5 M Tris-HCl pH 7.0. 
1.5M NaCl. 
Pre- hybridisation solution: 
6x SSC, 0.5% SDS, 100µg/ml Salmon sperm DNA. 
20x SSC: 
3 M NaCl, 300 mM Na-citrate pH 7.0. Autoclave at 121°C, 20 min. 
SM buffer:  
0.58g NaCl, 0.2g MgSO4.7H20, 5.0 ml of 1M Tris-HCl (pH7.5), 0.5ml of 2% 
(w/v) gelatin, add distilled water to a final volume of 100ml. Autoclave at 
121°C, 20 min. Store at +4°C. 
 
- Protein Analysis Media: 
  
Bacteria Lysis buffer:  
400 mM NaCl, 50 mM NaH2PO4,,15 mM Imidazole, adjust pH with NaOH to 8. 
Destain: 
Stain solution without Coomassie Blue 
Dialysis buffer: 
400 mM NaCl, 50 mM NaH2PO4, 10% Glycerol, 5mM MgCl2. 
Elution buffer 1:   
400 mM NaCl, 50 mM NaH2PO4, 50 mM NaH2PO4, 100 mM Imidazole, Adjust 
pH with NaOH to 8.0 
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Elution buffer 2:   
400 mM NaCl, 50 mM NaH2PO4 , 200 mM Imidazole, adjust pH with NaOH to 
8.0. 
Elution buffer 3:  
400 mM NaCl, 50 mM NaH2PO4  300 mM Imidazole, adjust pH with NaOH to 
8.0. 
1x PBS: 
137 mM NaCl, 2.7 mM KCl, 6.5 mM Na2PO4, 1.5 mM KH2PO4, pH7.5. 
PBS-Tween. 
1x PBS, 0.05% (v/v) Tween 20.         
NOP buffer: 
10 mM Tris/HCl pH 7.8, 150 mM NaCl, 1 mM MgCl2.6H20, 0.75 mM 
CaCl2.2H20, 2% Nonidet P4O. Store at +4°C. 
Reduction solution: 
10% ethanol, 0.25% of 37% Formaldehyde, 6% citric acid. 
SDS Sample buffer (6X):       
   300 mM Tris.Cl (pH 6.8), 600mM dithiothreitol, 12% SDS, 0.6% Bromophenol 
   blue, 60% glycerol. 
Silver solution: 
1). Dissolve 0.6g AgNO3 in 10 ml water  
2). 1.9 ml 1 M NaOH, 15 ml 32% Ammoiaque, add 96 ml water. 
Drop 2) in 1) until the solution becomes colourless and fill up to 100ml with 
distilled water. Protect against light. 
Coomassie Stain.    
0.25g Coomassie Brilliant Blue R250, 90ml Methanol:water (1:1), 10 ml acetic 
acid. 
Transfer buffer: 
25 mM Tris, 192 mM glycine, 20% (v/v) methanol. 
Tris/ glycine Electrophoreses buffer. 
  25 mM Tris, 192 mM glycine, 0.1% (w/v) SDS. 
Wash buffer:    
400 mM NaCl, 50 mM NaH2PO4, 20 mM Imidazole, Adjust pH with NaOH to 8. 
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Reporter Gene Assay Media: 
β-galactosidase 100x Mg solution: 
0.1 M MgCl2, 4.5 M ß-Mercaptoethanol. 
Luciferase assay buffer: 
20 mM tricine, 1.07 mM (MgCO3)4  Mg(OH)2.5H20, 2.67 mM MgSO4, 0.1 mM 
EDTA, 33.3 mM DTT. 
5x Luciferase assay cell lysis buffer: 
125 mM tris, pH 7.8 (corrected with H3PO4), 10 mM CDTA, 10 mM Dithiotritrol 
(DTT), 50% glycerin, 5% triton.  
Luciferase assay substrate for 10 ml assay buffer: 
2.12 mg Coenzyme A, 1.32 mg Lusiferin, 2.92 mg ATP. 
1x O-nitrophenyl-ß-Galactopyranoside (ONPG) solution: 
6µl of 100x Mg solution, 132µl 1x ONPG, 60µl cell extract, 402µl of 0.1 M 
Sodium   Phosphate, pH 7.5. 
0.1 M Sodium Phosphate, pH 7.5: 
41 ml 0.2 M Na2HPO4.2H2O, 9 ml 0.2 M NaH2PO4.H2O, 50 ml H2O. 
 
- Yeast Culture and Analysis Media: 
10 x LiAc: 
1 M Lithium acetate. 
10 x TE: 
100 mM Tris pH 7.5, 10 mM EDTA.  
Yc Medium: 
0.12% yeast nitrogen base, 0.5% ammonium sulfate, 1% succinic acid, 0.6% 
NaOH, 2% glucose, 0.1% (adenine, arginine, cysteine, leucine, lysine, 
threonine, tryptophan, uracil), 0.005% aspartic acid, histidine, isoleucine, 
metheonine, phenylalanine, proline, serine, tyrosine, valine). Autoclave at 
121°C, 20 min, cool to < 50°C and add ampicillin to 50µg/ml, Store at +4°C. 
Yc Medium-Agar: 
Yc medium, 2% agar. Autoclave at 121°C, 20 min, cool to < 50°C and add 
ampicillin to 50µg/ml. Pour plates and allow to harden. Store at +4°C. 
YEPD medium: 
1% yeast extract, 2% tryptone, 2% Dextrose (D-glucose). Autoclave at 121°C, 
20 min, cool to < 50°C and add antibiotic to 50µg/ml, Store at +4°C 
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Yeast lysis buffer: 
2.5 M LiCl, 50 mM Tris.HCl, 4% Triton X-100, 62.5 mM EDTA.  
Z-buffer: 
60 mM Na2HPO4, 40 mM NaH2PO4, 10 mM KCl, 1 mM MgSO4, pH 7.0.  
1x LiAc/40% PEG-3350/1xTE: 
100 mM Lithium Acetate, 40% PEG-3350, 10 mM Tris-HCl, pH 7.5. Autoclave 
at121°C  for 20 min. 
 
-Cell Culture media: 
APBS:  
2.7 mM KCl, 0.15 mM KH2PO4, 103 mM NaCl, 0.7 mM Na2PO4, pH 7.5.  
Blocking solution:  
1% BSA in APBS/ 2 mM CaCl2. 
Danaturation solution:  
1% Triton in APBS/ 2 mM CaCl2. 
Fixing solution:  
10% Paraformaldehyde in APBS/ 2 mM CaCl2. 
10x HeBS:  
1.36 M NaCl, 0.05 M KCl, 7 mM Na2HPO4, 1% (w/v) glucose, 0.2 M Hepes, pH 
7.0 adjusted with NaOH 
1x HeBS:  
1: 10 dilution of 10x HeBS, pH 7.12 adjusted with NaOH. 
Wash solution:  
APBS/ 2 mM CaCl2. 
 
- Embryo Cultivation and Manipulation Solutions:  
 
10x MBSH (Modified Barth’s Saline): 880 mM NaCl, 100 mM HEPES, 10 
mM KCl, 24 mM NaHCO3, 8 mM MgSO4, 4 mM CaCl2, 3.3 mM Ca(NO3)2 (pH 
7.3) 
Cysteine solution: 2% (w/v) L-Cysteine Hydrochloride in 0.1x MBSH (pH 8.2) 
Human Chorionic Gonadotropin (HCG): 3300 IU/mg; stock solution: 1 
mg/ml in sterile 0.5% NaCl.  
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4.       Methods. 
4.1      Molecular biology methods  
4.1.1   DNA methods  
4.1.1.1  DNA Purification. 
 
DNA purification can be carried out by binding to silica gel matrix under high salt 
condition and low pH followed by washing steps and DNA elution under low salt 
concentration and basic pH.  
For purification of DNA fragments from agarose gels, this was done using the 
QIAGEN QIAquickR gel extraction kit. Each DNA fragment is excised from the gel 
using a sharp clean blade and transferred into a clean 1.5ml tube. The gel is melted 
at 50°C in 3 gel volumes of buffer QG and then 1 volume of isopropanol added. To 
bind DNA to the silica matrix, the sample is applied to the QIAquick column, 
centrifuged at 13,000 rpm for 1 min to eliminate impurities and washed with buffer 
PE. The bound DNA is eluted with nuclease-free water in a volume of 50µl. 
For purification of plasmid DNA, QIAGEN small-scale purification (Minipreps) or large 
scale purification (Midipreps) were employed depending on necessity. 
For purification of PCR products, the QIAquick PCR purification kit (Qiagen) was 
used. To one volume of PCR product, 5 volumes of DNA binding buffer (PB) are 
added and the mixture is applied to the QIAquick column. Following centrifugation at 
13,000rpm to eliminate impurities, the column-bound DNA is washed with 0.75 ml of 
buffer PE. DNA is eluted with nuclease-free water in a volume of 30µl.  
 
4.1.1.2      Sequencing 
 
DNA sequencing was done using the enzymatic method of Sanger et al., in 1977 
which is based on in vitro DNA synthesis carried out in the presence of chain-
terminating nucleoside triphosphates. This method uses standard primers (T3, T7, 
SP6, M13) or sequence-specific primers and four dideoxyribonucleoside 
triphosphates as terminators in separate DNA synthesis reactions on the same 
primed single-stranded DNA template. These four dideoxyribonucleoside 
triphosphates are covalently linked to different fluorescent dyes and blocks the 
addition of subsequent deoxyribonucleoside triphosphate and thus prevents their 
incorporation into a DNA chain due to the absence of a 3' hydroxyl group. As a result, 
the chain-extension reaction yields a series of DNA fragments in each of the tubes. 
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These fragments are then separated in four parallel lanes by polyacrylamide gel 
electrophoresis. This leads to a series of bands, each with the fluorescence spectrum 
indicating a successive base in the DNA being sequenced.  
 
4.1.1.3    Quantification of DNA and RNA 
 
Due to their characteristic absorption maximum at 260 nm, nucleic acids can be 
photometrically quantified. Contaminations with proteins which have an absorption 
maximum at ultraviolet wavelengths of 280 nm can influence the result. Therefore, 
the ratio of absorptions at both 260 nm to absorption at 280 nm (A260/A280) greater 
than 1.9 for DNA, or greater than 1.8 for RNA is indicative of samples that are free of 
these contaminants. For uncontaminated nucleic acid solutions the law of Lambert-
Beer is applied: 50 µg/ml double-stranded DNA has an OD260 of 1.0 while 40 µg/ml 
single-stranded DNA or RNA has an OD260 of 1.0. 
 
4.1.1.4    Restriction digestion of DNA 
 
This was done according to Sambrook et al, 1989. In a final volume of 20µl, plasmid 
DNA (10µg) is digested overnight  at 37°C using appropriate restriction enzyme (1U), 
buffer (1x) and water. The digests are separated on a 1% agarose gel in 1x TAE 
buffer at 100V.  
 
4.1.1.5    Dephosphorylation of 5´- Phosphate residues from DNA 
 
Shrimp alkaline phospatase (SAP) removes 5´-Phosphate residues from DNA and 
prevents vector self-religation. 
In a 1.5 ml reaction tube 2.5 µg of linearised vector DNA is incubated at 37°C for 30 
min. with 1x SAP buffer, 0.5U SAP and water in a final volume of 20µl. The reaction 
is further incubated with additional 0.5U SAP 37°C for 30 min. The reaction is then 
stopped by inactivating the enzyme at 65°C for 15 min.  20ng of the 
dephosphorylated plasmid is used for ligation reactions.  
 
4.1.1.6    Polymerase Chain Reaction (PCR) 
 
Amplification was performed with Advantage polymerase mix which is a mixture of 
Taq polymerase and Deep Vent polymerase with a proofreading activity to lower 
error frequency. 
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To a final volume of 50µl, reaction buffer (1x), nucleotide mix (2.5mM each), primer 
(25µM each) MgSO4 (25mM), 10ng DNA template, 1U Advantage Enzyme mix and 
water is added. The PCR is run for 36 cycles with an initial predenaturation step of 
94°C, 2 min. All cycles are comprised of a denaturation step of 94°C, 2 min., an 
annealing step of 55°C, 2 min. and a polymerisation step of 72°C but with a time of 2 
min that increases every three cycles by 20 sec. Following a final elongation step of 7 
min that terminates the reaction the sample is stored at 4°C until analysed on an 
agarose gel. 
 
4.1.1.7     Recovery of DNA from agarose gels 
 
Nucleic acids have a consistent negative charge and can be separated in an electric 
field based on the difference in their nucleotide lengths. In Ultra-violet light DNA 
bands can be detected by fluorescent ethidium bromide which intercalates between 
the stacked bases of DNA (Sharp et al., 1973).  
The digest or PCR product are analysed on a 1% (w/v) agarose gel in 1x TAE buffer 
containing 0.05mg/ml ethidium bromide at 100V. The gel is visualised under long 
wavelength ultra-violet (312 nm) lamp in order to minimise radiation damage to DNA. 
The fragment sizes are characterised by comparison with the Ready-LoadTM 100bp 
DNA ladder standard molecular weight marker. Bands are documented with the Gel 
Max (Intras) or Diana II (raytest) documentation system.   
 
4.1.1.8    Sticky-End Ligation of DNA Fragments into Plasmids 
 
Ligation of cohesive DNA termini can be achieved by T4 DNA ligase which 
associates the free 3´-hydoxyl terminus of one nucleotide of a DNA fragment to the 
free 5´-phosphate terminus of another. Sticky-end ligation has the advantage of 
controlled insert integration with predefined orientation. Ligation is done as described 
by Sambrook et al., 1989.  
Briefly, 100pg of linearised dephosphorylated plasmid vector to insert ratio of 1:5 is 
incubated with T4 DNA ligase (1u/10µl) and 1X ligase buffer in a total volume of 10µl 
at 14°C for 16h. 5µl of the ligation mixture is used in transforming 100µl competent E. 
coli  strain JM109 cells prepared by Calcium Chloride method.  
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4.1.1.9    DNA probe Labelling 
 
A labelled radioactive probe was used for screening of the Xenopus tail bud library. 
This labelling is done using the Random primed DNA labelling kit and is based on the 
hybridisation of a mixture of all possible hexanucleotides to the DNA to be labelled. 
The probe is synthesised from the 3´OH termini of the random hexanucleotide primer 
using Klenow enzyme. Modified deoxnucleoside triphosphates eg  32P-dCTP present 
in the reaction mixture are incorporated into the newly synthesised complementary 
DNA strand.  
A 510 bp fragment of Hic-5 previously obtained by RT-PCR from Xenopus tissue 
culture cell (XTC) using degenerate primers is denatured at 100°C for 10 min.  Into a 
1.5 ml reaction tube, 25ng of the denatured DNA, 1µl each of 0.01 mM dATP, dGTP, 
dTTP, 2µl of 10x reaction mixture, 5 x10-6 mM [α32P] dCTP, distilled water is added 
up to 19µl and 1µl of 2U Klenow enzyme. The mixture is incubated at 37°C for 30 
min. and the reaction stopped by heating to 65°C for 10 min.  Removal of non-
incorporated dexoxyribonucleoside triphosphates is performed by chromatography on 
Quick Spin Column, SephadexR G-50 (Amersham). 
 
4.1.1.10    Determination of the appropriate phage dilution to use for plating 
 
It is necessary to determine the appropriate phage dilution to use for plating in order 
to avoid confluence of plaques. Cells previously stored in 10mM MgSO4 are further 
diluted to an OD600nm of 0.5 with 10mM MgSO4 and 7 samples of 200µl taken into 
sterile 15ml reaction tubes. To these tubes, 100µl of phage library diluted in phage 
storage medium (SM) with dilutions ranging from 1:103-1:109 are added respectively. 
Cells are incubated at 37°C for 20 min to allow the phage to attach to the cells and 
plated on 150 x 20mm 2YT agar plates with 3ml 2YT top agar. Plates are allowed for 
the agar to set for 10 min. and then incubated for 6-8 h at 37°C for plaques to 
appear. The phage dilution of 1:105 was found to give about 5,000 plaque forming 
units (pfu) per plate and without confluence. This dilution was subsequently used for 
plating. 
 
4.1.1.11     Plaque Lifts 
 
The phage library is diluted 1:105 in SM buffer and 100µl used to infect 16 samples of 
200ml each of XL-1B E. coli at an OD of 0.5 in 10mM MgSO4 .  samples are 
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incubated at 37°C for 20 min. and plated with 3ml 2YT top agar on at least two days 
old 2YT agar plates and incubated at 37°C for 8h. The plates are placed at 4°C 
overnight to harden so as to prevent subsequent sticking of agar onto the 
nitrocellulose membrane. Plates are given numbers and oriented by punching 
through the agar with a cut pipette tip. To allow transfer of colonies to the 
nitrocellulose membrane, a circular nitrocellulose membrane is placed on each the 
plates for 2 min. The membrane is also given corresponding numbers and oriented 
by pricking through the membrane with a needle to correspond to the punched agar 
wells. The membrane is lifted and the bound DNA is denatured in denaturing solution 
for 2 min., neutralised in neutralisation solution for 2 min. and rinsed for 30 sec in 
0.2M Tris-HCl (pH7.5)/2x SSC. The membrane is blotted on Whatman 3MM paper 
and DNA cross-linked to it by backing in the oven at 85°C for 2h. Filters are blocked 
in 50ml prehybridisation buffer for 4h at 65°C with rotation and  incubated with 10-6 
mM 32P-labelled probe in 50ml hybridisation buffer. Filters are washed successively 
with 50ml changes of 6x SSC/0.1%SDS, 2x SSC/0.1%SDS and 0.2x SSC/0.1%SDS 
at 65°C for 2h each wash with rotation. Filters are then dried and exposed to the 
phosphoimaging plate overnight and revealed by a phosphoimager. The image is 
superimposed with the corresponding agar plate and colonies giving signals are 
cored and stored in 1ml phage storage medium (SM) containing 40ml chloroform at 
4°C for phages to be eluted from the agar. The eluted phages are further  purified in 
three rounds of plaque lifts. 
 
4.1.1.12     In-vitro excision 
 
The λ-Zap Library is designed such that a pBluescript vector carrying the library 
insert is cloned between a replication initiation site and a replication termination site 
in the λ-Zap II vector. Inside E. coli the filamentous (f1) bacteriophage (helper phage) 
proteins recognise these replication initiation sequences and introduces a nick at that 
point so that replication starts. This replication continues until it reaches the 
termination sequence where it stops.  The single stranded DNA comprised of the 
pBluescript and the insert is circularised and automatically creates a functional origin 
of replication as in bacterophages and can be replicated. This procedure circumvents 
the sub cloning step. 
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Separate 50ml overnight cultures of XL1-Blue cells are cultured overnight at 30°C in 
LB medium containing 50µg tetracycline. Cells are harvested at 1,000xg and 
resuspended in 25ml 10 mM MgSO4 and further diluted with 10 mM MgSO4 for 
OD600nm to read about 1.0. In a 15ml tube each, 200µl XL1-Blue cells (OD600nm of 
approximately 1.0), 250µl of phage stock and 1µl helper phage (R408) are added and 
incubated at 37°C for 15 min. to allow phage to attach to the cells. 5ml 2YT broth 
supplemented with tetracycline are added and tubes incubated at 37°C for 3h with 
shaking. The tubes are heated at 70°C for 20 min. to lyse the λ-phage particles and 
spun at 4000g for 15 min to pellet debris. The supernatant containing the pBluescript 
phagemid packed as filamentous particles is decanted into sterile 15ml tubes. To 
200µl of XL1-Blue cells in a 1.5ml reaction tubes, 10µl of the pBluescript phagemid 
are added and incubated at 37°C for 15 min. Samples are plated on 50µg/ml 
ampicillin agar plates and incubated overnight at 37°C. The colonies that grow are 
those that have been transformed by the pBluescript. Colonies are re-grown in liquid 
culture medium and pBluescript extracted by miniprep method, sequenced and 
blasted against the NCBI data bank. 
 
4.1.2       RNA Methods 
 
4.1.2.1    RNA extraction from Xenopus embryos 
 
Total RNA from whole embryos are isolated using Trizol Reagent. Injected embryos 
are allowed to develop to the desired stage and are then used for RNA isolation or 
immediately frozen in liquid nitrogen and stored at -70°C for later use. 
1 ml of Trizol Reagent is sufficient for the total RNA isolation from 10-20 embryos, 
equivalent to 50-100 mg of tissue. Trizol Reagent is a mixture of phenol and 
guanidine isothiocyanate, and is able to dissociate nucleotides from proteins and 
maintain the RNA integrity. After washing the ultrasonic homogeniser pistil in Trizol 
Reagent and rinsing in water whole embryos samples are rapidly homogenized in 
500µl of Trizol Reagent until all pieces are crushed. For removal of proteins, 100µl 
chloroform are added to the homogenate and vigorously agitated by hand for 15 sec. 
After centrifugation for 15 min. at 10,000g (maximum speed) at 4°C, the upper 
aqueous phase contains the RNA and is transferred into a sterile tube. A second 
chloroform extraction is performed and RNA is precipitated at -80 °C for at least 1h 
with two volumes of absolute ethanol and 1/10th volume 3M sodium acetate solution. 
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Following 30 min. centrifugation at 10,000g the RNA pellet is washed with 70% 
ethanol, dried at RT re-dissolved in an appropriate volume of DEPC H2O. 
4.1.2.2      In vitro transcription 
 
4.1.2.2.1    Reverse transcription PCR 
 
The reverse transcriptase, a retroviral DNA polymerase, uses RNA as a template to 
transcribe isolated mRNA into cDNA which can be later used for PCR. This RT-PCR 
permits semi-quantitative analysis of expression of RNAs of interest during 
embryonic development when compared to a standard housekeeping gene. 
Into a nuclease-free microcentrifuge tube 1 µg of total RNA and 1µl Random 
Hexamer (0.5 µg/µl) are added. After mixing by pipetting, the mixture is heated at 
70°C for 10 min. and quickly chilled on ice to allow Random Hexamer to bind to 
mRNA. The sample is briefly centrifuged and 4 µl of 5x first strand buffer, 2 µl 10 mM 
DTT, 1 µl 10 mM dNTP mix and 1U RNase inhibitor are added to the sample. After 
gently mixing, 0.5µl (100 U) of reverse transcriptase (Superscript II, Gibco BRL) is 
added. The reaction is incubated at 42°C for 50 min. then inactivated by heating at 
70°C for 15 min. and stored at -70°C or used directly for PCR. To control specificity 
of reverse transcription, -RT is also performed using all the other components 
together with DEPC H2O instead of the reverse transcriptase. 
 
4.1.2.2.2      Preparation of mRNA for injection 
 
Messenger RNA (mRNA) can be transcribed from a DNA template using RNA 
polymerase and free ribonucleoside triphosphates. mRNA was prepared using the 
mMESSAGE mMACHINETN kit (Ambion Ltd) 
In a total reaction volume of 20µl, linearised and PCR-purified plasmid (1µg) is 
incubated for 2h at 37 °C with 2x Nucleoside triphosphates, 1x reaction buffer, 1 unit 
RNA Polymerase enzyme specific for SP6 or T7  and water.  The DNA template is 
then digested by adding10U  DNase 1 and incubating further for 15 min. at 37 °C. 
The RNA is cleaned by passing it over a RNeasy column (Qiagen) and eluting with 
30µl of RNase-free water. 
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4.1.3        Protein Biochemistry Methods 
 
4.1.3.1     Induction of encoded peptides 
 
Large amounts of eukaryotic proteins can be obtained in E. coli BL21 DE3 by placing 
the gene under the control of a Lac-Z operon in a T7 RNA polymerase vector. The 
lactose analogue Isopropyl-(β)-D-thiogalactopyranoside (IPTG) can then be used to 
derepress the promoter for the gene to be expressed.  
An overnight culture of a single transformed colony is diluted 1: 100 in 500ml LB 
medium containing the appropriate antibiotic and cultured at 37°C with vigorous 
shaking until the OD600 read 0.7. Protein expression is induced by adding IPTG to a 
final concentration of 1 mM and shaking continued at but 30°C (to reduce protein 
degradation) for 4 h. An aliquot of 300µl is taken out after the 4h induction, 
centrifuged at 13,000 rpm for 1 min., re-suspended in 60µl SDS PAGE loading buffer 
and heated at 95°C for 20 min. This sample is run on a 10% SDS PAGE gel and 
induced protein band of interest identified. The rest o the bacteria is centrifuged in 
aliquots of 100ml at 5,000rpm for 5 min. and pellet frozen at -80°C until used for 
protein extraction.  
 
4.1.3.2     Protein extraction 
 
Transformed and frozen bacteria are thawed on ice for 30 min. and re-suspended 
in1ml of PBS supplemented with 400 mMNacl containing protease inhibitors. To 
disrupt the cell wall lysozyme is added to a concentration of 1mg/ml and incubated 
for 30 min on ice. To shear RNA and DNA, RNAse A, and DNAse I are added to a 
final concentration of, 10µg/ml and 5µg/ml respectively and the sample incubated on 
ice for 15 min. The sample is transferred to 2 ml reaction tubes and centrifuged at 
13,000g for 30 min. to eliminate cell debris. The supernatant (crude lysate) is saved 
as 200ml crude lysate samples in liquid nitrogen until used for protein purification or 
GST pull-down assays. 
 
4.1.3.3    Purification of Histidine-tagged proteins 
 
Recombinant proteins provided with a 6x Histidine-tag can coordinatively bind to 
transition metals (Ni, Co, Zn) attached to an agarose column. Proteins without the 6x 
Histidine-tag bind weakly and can be washed off with low imidazole concentrations. 
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The bound recombinant protein can be eluted with high concentrations of imidazole 
whose structure is similar to that of histidine and thus competes with the histidine 
side chain for binding to the metal.  
200ml crude bacterial lysate of induced proteins are rotated with 50µl of washed 
Nickel nitrilo triacetic acid (NTA)-agarose in binding buffer pH 8.0 at 4°C for 2h. 
Following 3 times washing steps each with 2ml wash buffer the protein is eluted 3x 
with 1ml elution buffer. The eluted protein is dialysed with 3x 200ml dialysis buffer to 
eliminate the imidazole. Samples are stored as 200µl samples in liquid nitrogen until 
used for GST pull-down experiments. 
 
4.1.3.4    Immobilisation of GST-tagged proteins on sepharose columns 
 
Glutathione-S-transferase (GST) enzymes catalyse the detoxification of reactive 
electrophiles through the reactive cysteinyl residue in their cofactor glutathione 
(GSH). The high affinity of GST for GSH has been employed in the purification of 
GST-tagged proteins on GSH sepharose gels.  
200ml crude bacterial lysate of induced proteins are incubated with 50µl of washed 
GSH sepharose gel in phosphate buffered saline (PBS) supplemented with 400 mM 
NaCl containing protease inhibitors at 4°C for 2h. Following three washing steps 
each with 2ml PBS supplemented with 400 mMNacl the gel is used for GST pull-
down assays. 
  
4.1.3.5      GST Pulldown assays 
 
Bacterially expressed GST-tagged proteins are immobilised on 50µl of Glutathione 
sepharose 4B beads for 2h at 4°C in NOP buffer and incubated with NOP-lysates of 
transfected or untransfected human kidney epithelial cells (h293). Binding reactions 
are rolled for 2h at 4°C and washed 3 times with NOP buffer. Following 3x 15 min. 
washing steps, the beads are boiled in SDS sample buffer for 5 min. and subjected to 
10 or 12 % SDS PAGE and run at 100V. At the end of the run the gel is stained with 
either Coomassie brilliant blue or Silver. For Coomassie-stained gels the band of 
interest is cut out, digested with tripsin and analysed by MALDI-TOF. MALDI-TOF 
analysis was done in collaboration with Marc Genzel, EMBL, and Heidelberg.  For 
Western blotting proteins are transferred onto nitrocellulose membrane, probed with 
anti myc antibody 9E10 and revealed by chemiluminescence reaction.  
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35S-labelled in vitro-translated proteins are also incubated with GST-tagged proteins 
immobilised on sepharose beads in NOP buffer. Following five washes with NOP 
buffer and elution with 20µl SDS sample buffer, the proteins are separated on a 10% 
SDS PAGE gel. After Coomassie staining the gel is subjected to phosphorImager 
analysis to visualise bound protein.   
 
4.1.3.6     In vitro-translation 
 
The use of in vitro translation systems have advantages over in vivo gene expression 
when the overexpressed product is toxic to the host cell, when the product is 
insoluble or forms inclusion bodies, or when the protein undergoes rapid proteolytic 
degradation by intracellular proteases. The in-vitro translated protein can be radio-
labelled with 35S-Methionine so that emitted radioactive rays can be detected by a 
phosphoimaging film.  
In-vitro translation of protein was done as described by the TNTR coupled reticulocyte 
lysate system (Promega).  
 
4.1.3.7       Sodium Deodecyl Sulphate (SDS) Polyacrylamide Gel  
        Electrophoresis (PAGE) 
 
Under denaturing conditions proteins are separated in to their individual polypeptide 
subunits. Most commonly, the strongly anionic detergent SDS in combination with 
reducing agents and heat are used to dissociate the protein before they are loaded 
on the gel. The SDS molecules interact with the proteins to form negatively charged 
complexes containing a constant ratio of approx. 1.4mg of SDS per mg of protein. At 
this ratio, the charge density per unit length of proteins is equal. As a result, all 
proteins are separated in accordance with charge density and consequently with 
respect to the sizes of the polypeptides. By using markers of known molecular 
weight, it is therefore possible to estimate the molecular weight of the polypeptide 
chains. In this work a 10 or 12% separating gel and a 5% stacking were prepared 
according to the table 1.  
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Table1: Recipe for preparation of the Stacking gel (5%) and the separating gel 
(10% or 20%). 
         
                     Solution 
         5%  
Stacking Gel
          10% 
Separating Gel 
    12% Gel 
Separating Gel
Water 1.4ml 1.9 ml 1.6 ml 
29% Acrylamide,1% bisacrylamide 0.33 ml 1.7 ml 2.0 ml 
1.5 M Tris-Cl pH 8.8 - 1.3 ml 1.3 ml 
0.5 M Tris-Cl pH 6.8 0.25 ml - - 
10% SDS 0.02 ml 0.05 ml 0.05 ml 
Ammonium persulfate (1mg/ml) 0.02 ml 0.05 ml 0.05 ml 
TEMED (Tetramethyethelediamine) 0.002 ml 0.002 ml 0.002 ml 
Total volume  2.0 ml 5.0ml 5.0ml 
 
The separating gel is poured between two glass plates and allowed to polymerise at 
room temperature (RT). In a similar manner the stacking gel is poured and a ten-
teeth comb inserted. The gel is allowed to polymerise and the comb removed to 
create wells in which the samples will be applied. The gel is mounted into the 
electrophoresis apparatus containing 1x Tris-glycine electrophoresis buffer and 10-
20µ samples applied. The gel is run with at 100V and is either blotted, stained with 
Coomassie Brilliant Blue R250 or by the silver method to reveal bands. 
 
4.1.3.8     Coomassie Staining  
 
Coomassie Brilliant Blue R250 is a dye that binds to proteins by hydrophobic and 
ionic interactions and can be used for detection of protein amounts as less as 100ng. 
The gel is immersed in at least 5 gel volumes of dye and slowly rocked for about 20 
min and rinsed with tap water. The gel is distained in three changes of distain 
solution dried and scanned for documentation.  
 
4.1.3.9     Silver Staining 
 
Silver ions form complexes with aspartic acid, cystein and glutamic acid and are 
reduced by alkaline formaldehyde to elemental silver resulting into a brown staining. 
Silver staining is at least 100 fold more sensitive than coomassie since protein 
amounts as less as 0.1ng protein can be detected. 
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The gel is fixed overnight in 100ml methanol: acetic acid: water (50:12:38). The gel is 
then washed in 100ml ethanol: acetic acid: water (10:5:85) for 20 min and then in 
excess water for 20 min. It is reduced with100ml Na2B4O7 (1.9%w/v)/4% 
gluteraldehyde/distilled water and washed 3x 20 min. with distilled water. The gel is 
incubated in silver solution for 20 min in the dark in order to avoid oxidation by light. 
After 4 washing steps of 1 min. each, bands are developed in reduction solution 
under visual control. The reaction is then stopped with 7% acetic acid, washed 2x 20 
min. with water, stored in 7% acetic acid for eventual documentation.  
 
4.1.3.10 Analysis of protein bands from SDS PAGE by mass spectrometry 
 
This is a procedure where a protein or peptide is degraded under controlled 
conditions using a chemical reaction or specific enzymes. After purification by means 
of High Performance Liquid Chromatography (HPLC), protein fragments subjected to 
a Matrix-Assisted Laser-Desorption Ionization (MALDI). MALDI is based on the 
bombardment of sample molecules into ions with a laser light to bring about 
ionization. The sample is pre-mixed with a highly absorbing matrix compound which 
transforms the laser light into excitation energy leading to sputtering of analyte and 
matrix ions. In this way the analyte molecules are spared from excessive direct 
energy which may otherwise cause decomposition. The Time Of Flight (TOF) 
analyser then separates the ions according to their mass (m) to charge (z) ratio by 
measuring the time it takes for ions to travel through a region known as the flight or 
drift tube. The heavier ions move slower than the lighter ones. TOF values are then 
matched with those of the World Wide Web databases where masses of proteolytic 
peptides expected from enzymatic degradation of proteins of known sequences can 
be found.  
 
4.1.3.11      Western Blotting 
 
Electrophoretically separated proteins can be transferred from a gel to a solid support 
(nitrocellulose membrane) and probed with antibodies that specifically recognise the 
proteins.  
At the end of the SDS page run, the gel is removed and placed in transfer buffer. 
Four pieces of Whatman 3MM paper and a piece of nitrocellulose (NC) membrane 
are cut to the exact size of the SDS polyacrylamide gel. The NC membrane, pieces 
of Whatman 3MM paper and two porous pads are allowed to soak in transfer buffer 
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by capillarity in order to avoid trapping of air bubbles. The electrodes are assembled 
to sandwich the gel, NC membrane, pieces of Whatman 3MM paper and the two 
porous pads in the following order: 
Cathode 
Porous pad 
Two pieces of Whatman 3MM paper 
Nitrocellulose membrane 
Gel 
Two pieces of Whatman 3MM paper 
Porous pad 
Anode. 
The set is mounted into a Western blotting apparatus (Bio Rad) containing electrode 
buffer and equipped with a cooling system. Transfer is done at 111V for 1h.  
 
 4.1.3.12      Staining proteins immobilised on nitrocellulose (NC) membrane by  
                    Ponceau S. 
 
To provide visual evidence that transfer of proteins has taken place the NC 
membrane is stained with Ponceau S which specifically binds to protein band giving 
them the characteristic purple colour.  
Proteins are transferred onto transfer NC membrane and  incubated with Ponceau S 
for 5-10 min. with gentle agitation. The membrane is then washed with several 
changes of distilled water at room temperature and the positions of proteins used as 
molecular weight standards are marked with a waterproof ink. The membrane is then 
proceeded to immunological staining. 
 
4.1.1.13  Immunological staining 
 
Proteins are transferred onto nitrocellulose membrane and potential non specific 
binding sites of the membrane were blocked in 5% (w/v) non fat dried milk for 1h and 
the filter incubated overnight with rotation in anti-myc primary antibody (9E10). 
Following 3x 15 min washes in PBS/0.05%Tween 20 the filter is incubated for 2h at 
RT with gentle agitation in the secondary antibody (Goat anti-mouse antibodies 
coupled to horse radish peroxidase). Following three washing steps of 15 min each in 
PBS/Tween, bands are revealed by chemiluminescence reaction (ECL, Amersham). 
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4.1.1.14    Chemiluminescence 
 
Luminescence is the emission of light by a substance. It occurs when an electron 
returns to the electronic ground state from an excited state and loses it's excess 
energy as a photon. Chemiluminescence occurs when a chemical reaction produces 
an electronically excited species which emits a photon in order to reach the ground 
state. In the presence of peroxides, horse radish peroxidase (HRP) catalyse the 
oxidation of lumigen PS-3 acridian substrate to acridium ester intermediates which 
react with peroxide under slight alkaline conditions to give an excited product. This 
product emits light as it returns to the ground state and is detected by a CCD camera 
(DIANA, Raytest) as a distinct protein band. 
 
4.2        Microbiology methods. 
 
4.2.1       Bacteria manipulation methods 
 
4.2.1.2    Preparation of competent bacteria cells by CaCl2 method. 
 
From empirical experimentation, the efficiency of plasmid up-take by E. coli is 
improved by treatment with ice-cold solutions containing CaCl2 (Cohen et al., 1972).  
The cells, directly from a frozen stock (stored at -70°C in 15% glycerol) are streaked 
out on an antibiotic-free LB agar plate and incubated overnight at 37°C. A colony of 
1-2 mm in diameter is transferred into a sterile 1l flask containing 5 ml LB medium 
and incubated with shaking overnight at 37°C. Cells are then diluted 1:100 with LB 
medium supplemented with 20 mM MgSO4 and cultured with vigorous shaking at 
37°C until an OD600 of 0.4-0.6 was reached. Cells are then harvested by 
centrifugation at 4,500g for 5 min. at 4°C and gently re-suspended in 0.4x original 
volume of ice-cold transformation buffer (TFB) 1 and incubated on ice for 1h. Cells 
are again harvested at 5,000g for at 4°C then re-suspended in ice-cold 1/25 original 
volume of TFB 2. Following incubation on ice for 30 min. the cells are saved as 100µl 
samples and frozen immediately at -80°C.  
 
4.2.1.3    Transformation of competent E. coli cells 
 
To 100µl aliquot each of competent cells thawed on ice 1- 5ng plasmid DNA are 
added and incubated further on ice for a 30 min. After a heat-shock of 90 sec at 
42°C, the cells are placed on ice for 2 min. To allow expression of the antibiotic 
Methods 46
resistance gene of the plasmid, 900µl of LB medium are added and incubated with 
vigorous shaking at 37°C for 45 min. Cells are then harvested at 2000rpm for 2 min., 
re-suspended in 100µl of LB medium, spread on LB-agar plates containing the 
appropriate antibiotic and incubated overnight at 37°C.  
 
4.2.1.4     Blue/white colony screening 
 
When E. coli cells are transformed with a vector carrying E. coli Lac-Z gene, the 
enzyme is expressed as β-galactosidase enzyme following induction by Isopropyl-(β)-
D-thiogalactopyranoside (IPTG). This enzyme metabolizes its substrate 5-bromo-4-
chloro-3-indolyl-beta-D-galactopyranoside (X-gal) to a blue product. Insertion of 
foreign DNA into the lac-Z gene leads to insertional inactivation of the lac-Z gene 
product which can no longer metabolise its substrate and white colonies instead of 
blue are observed.    
Ligation mixture (5µl) of pGEM-T and insert is used to transform competent E. coli 
JM109 cells. The cells are plated on 50µg/ml ampicillin LB agar plates containing 20 
mg/ml X-gal in dimethyl formamide and 200 mg/ml IPTG and incubated O/N at 37°C. 
White colonies are picked and plasmid isolated using the Qiagen kit and sequenced. 
 
4.2.1.5      Library amplification 
 
Twenty five vials of 100µl E.coli JM109 strain are transformed each with 5ng of 
library DNA by CaCl2 method. Colonies are scrapped and re-suspended in 5ml LB 
medium. Plasmids minipreps are made and pooled into a single 1.5ml tube to 
constitute the amplified library. 
 
4.2.1.6     Preparation of E.coli XL-1Blue bacteria for phage infection 
 
The E.coli bacteria strain XL-1Blue is streaked on a 2YT agar plate containing 50µl 
tetracycline and incubated overnight at 37°C. Four colonies are used to inoculate 
30ml of antibiotic-free 2YT medium and incubated at 37°C with shaking until the 
OD600nm was about 1.0. Cells are then centrifuged at 2,000rpm at 4°C for 10min. and 
re-suspended in an equal volume of 10 mM sterile MgSO4.  Cells are used 
immediately for phage library tittering, plaque lifts or stored at 4°C for a maximum of 
24h. 
Methods 47
4.2.2      Yeast Two hybrid methods  
 
4.2.2.1    Yeast two-hybrid assay  
 
Yeast two-hybrid assays represent a versatile tool to study protein interactions in 
vivo. Two-hybrid assays are based on the fact that many eukaryotic transcriptional 
activators consist of two physically and functionally separable domains: a DNA-
binding domain (DBD) that specifically binds to a promoter and an activation domain 
(AD) that directs RNA polymerase II to transcribe the gene downstream of the DNA-
binding site. While these domains may be part of the same protein (as in the case of 
the native yeast GAL4 protein), they can also function as two separate proteins. The 
transactivation function can be restored when the DBD and the AD from the same or 
different transcription factor(s) are brought together by two interacting heterologous 
proteins which are the bait and the prey (Fig. 9).  
 
DBD 
Pol. 
                Promoter                          His3/Lac-Z dual reporter 
AD 
Pol. 
 Prey 
Bait A 
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                         His3/Lac-Z dual reporter                 Promoter  
 
 C Bait  Prey 
                         His3/Lac-Z dual reporter                Promoter 
AD 
Pol. 
DBD 
 
ON  
 
 
Fig. 9:  Principle of the yeast two hybrid system. A) Binding of the DBD-bait fusion alone to 
the promoter (A) or activation domain (AD)-prey fusion protein alone to the DNA polymerase 
II (Pol.) does not lead to target gene reporter. C) bait/prey interaction brings the DBD and the 
AD to close proximity and thus reconstitutes a functional transcription factor which activates 
the promoter. (Chien et al., 1991 with modification from Ghogomu S.M). 
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The bait is always a well characterized protein while the prey constitutes the inserts 
of a cDNA library. Binding of the DBD-bait fusion alone or the activation domain (AD)-
prey fusion is not sufficient to activate target gene reporter. Interaction between the 
bait and the prey brings the DBD and the AD to close proximity and a functional 
transcription factor is reconstituted which activates the reporter. Reporter activation is 
read either as growth on a histidine-deficient medium or appearance of blue colonies 
following β-galactosidae assay. In this work, an Escherichia coli repressor protein 
(LexA) served as DBD while VP16 protein (a herpes simplex virus protein that acts 
as a transcriptional activator in mammalian cells) served as AD.  
 
4.2.2.2     Preparation of sheared denatured salmon sperm DNA 
 
In a 250ml flask 0.5g of salmon sperm DNA is dissolved in 50ml TE buffer by 
pipetting up and down using a 10ml pipette and incubated overnight at 4°C. The DNA 
is sheared by sonifying twice for 30 sec. at 3.0 kV. Samples of 12.5ml are extracted 
with 12.5ml of TE-saturated phenol (to precipitate proteins) by mixing, centrifuging at 
10,000g for 5 min. at 4°C and transferring the upper aqueous phase to fresh 50ml 
tube. The sample is next extracted with 12.5ml of phenol:chloroform:Isoamyl alcohol 
(25:24:1) mixture and finally with 12.5ml of chloroform alone to remove residual 
phenol. In a 250ml centrifuge tube, the DNA is precipitated with 2.5 volume of ice-
cold (-20°C) 95% ethanol and 1/10 volume of 3 M sodium acetate pH 6.0. The DNA 
is harvested at 10,000g for 5 min at 4°C, washed once with 100ml of 70% ethanol 
and air-dried. The DNA is dissolved in 50ml sterile TE (10mg/ml) and denatured by 
boiling in a water bath for 20 min. Samples are cooled on ice and stored as 2ml 
samples at -20°C.  
 
4.2.2.3     Testing the bait for non specific activation of reporter constructs 
 
The bait is not supposed to non specifically transactivate the reporter constructs in 
the L40 strain or interact with either the nuclear localisation sequence (NLS) or the 
activation domain (AD) of the library plasmid. As a consequence the transformed 
strain should not grow in the absence of histidine or exhibit detectable β-
galactosidase activity. 
L40 yeast strain is streaked on an antibiotic-free YEPD plate and incubated at 30°C 
for 3 days. A single colony is used to inoculate 10ml of YEPD medium and incubated 
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overnight with shaking at 30°C. Cells are diluted to an OD600nm of 0.5 and cultured for 
an additional 3h.  Cells are harvested at 2,500rpm at room temperature (RT) and 
washed by re-suspension in 40ml TE followed by centrifugation.  Cells are re-
suspended in 2ml of 100 mM Lithium acetate (LiAc)/0.5x TE and incubated at RT for 
10 min. Into a 1.5ml reaction tube containing 100µl yeast suspension in LiAc/0.5xTE, 
1ug plasmid DNA (bait) and 100ug denatured, sheared salmon sperm DNA, 700µl of 
100 mM LiAc/40% Polyethylene glycol-3350/1x TE are added. The mixture is 
vigorously agitated and incubated at 30°C for 30 min. Following addition of 88µl 
DMSO, the sample is mixed, heat shocked at 42°C for 7 min. and cells harvested at 
2,500prm for 10sec. Cells are washed by re-suspension in 1ml TE buffer and re-
centrifugation.  The pellet is re-suspended in 100µl TE and plated on 150 x 20mm 
agar plate deficient in tryptophane, uracyl and lysine (-Trp, -Ura and –Lys ) and 
containing 100µg/ml ampicillin). Plates are incubated at 30°C for 3 days after which 
colonies are then assayed for β-galactosidase activity. 
 
4.2.2.4     β-Galactosidase assay 
 
A dry circular nitrocellulose membrane is placed onto the yeast colonies for 2 min. 
The membrane is removed and placed colony-side-up on a pre-cooled aluminium 
boat floating in a sea of liquid nitrogen. After 30 sec the boat and the membrane are 
immersed in the liquid nitrogen for 5 sec. The membrane is then removed and placed 
colony-side-up at RT until thawed. In a 150 x 20mm Petri dish, 6.4ml of Z-buffer 
containing 25mg/ml X-gal are added. A circular 3MM Whatman filter is placed in the 
buffer followed by the thawed nitrocellulose filter colony-side-up avoiding trapping of 
bubbles. This is covered with the bottom of the dish and incubated at 30°C for 6h 
after which colonies analysed for observed for blue/white selection. 
 
4.2.2.5     Large scale library transformation   
 
A colony of L40 transformed with the bait plasmid is cultured overnight in 5ml of Yc 
medium lacking Triptophane, Uracil and Lysine (Yc/-Trp, -Ura and –Lys). The culture 
is diluted with the same medium to an OD600nm of 0.3-0.5 and re-cultured for 4 hours. 
Cells are washed by re-suspension in 500ml TE followed by centrifugation at RT for 
10min at 5,000rpm. Cells are re-suspended in 20ml of 100 mM (LiAc)/0.5 x TE and 
incubated at RT for 10min. Cells are mixed with 2ml of denatured sheared salmon 
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sperm DNA, 250µg library plasmid DNA (prey), 140ml of 100mM LiAc/40% 
polyethylene glycol-3350/1 x TE and incubated at 30°C for 30 min. The mixture is 
vigorously agitated and incubated at 30°C for 30 min. Following addition of 17.6ml 
DMSO, the sample is mixed, heat shocked at 42°C for 7 min. with occasional swirling 
and cells harvested at 5,000rpm for 10sec. Cells are washed by re-suspension in 
500ml TE buffer and re-centrifugation.  The pellet is re-suspended in 1l YEPD 
medium and cultured with aeration at 30°C for 1h to allow expression of antibiotic 
resistance genes and the reporters. Cells are washed with TE buffer, re-suspended 
in 1l Yc/(-Trp, -Ura  and –Lys) medium and cultured with aeration overnight at 30°C. 
Cells are harvested, washed twice with 500ml TE and re-suspended in 10ml TE. 
100µl samples are plated on twenty 150 x 20mm ampicillin Yc/(-Trp, -His, -Ura, -Leu 
and –Lys) agar plates and incubated at 30°C for 3 days. Colonies are then assayed 
for β-galactosidase activity. 
 
4.2.2.6     Perching of yeast strain transformed L40 of bait plasmid 
 
The scourge of the two hybrid system is the notorious ``false positives´´ arising from 
independent activation of the promoter by the bait or the prey. The best strategy for 
elimination of false positives is to test colonies for interaction with other LexA fusion 
partners. This is done by analysing the specificity of the interaction by mating 
colonies with a set of strains containing interacting and non interacting baits. But 
before mating, each colony is perched of the bait plasmid. Extended growth of L40 
transformed with both bait and prey plasmid in the absence of tryptophane (Trp) 
allows segregation and survival of the daughter cells without the bait plasmid. Cells 
from each colony are thus streaked on –Leu, +Trp plates and individual colonies are 
picked to both -Leu, +Trp and -Leu, -Trp (negative control). Colonies that grow on the 
-Leu, +Trp plates and not on the -Leu, -Trp plates are those that have lost the bait 
plasmid (Leu+,Trp-) and can be used for mating analysis. 
 
4.2.2.7     Mating of yeast strains 
 
In a 1.5ml tube containing 0.5ml of YEPD medium supplemented with 100µg/ml 
ampicillin, each colony perched of its bait is mixed with AMR70 yeast strain 
previously transformed respectively with the bait plasmid or the LexA-Lamin plasmid 
(negative control). Lamin is a nuclear protein found to interact with very limited 
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number of proteins. Cultures are grown overnight with aeration at 30°C and 10µl of 
each are spread on YEPD ampicillin plates and incubated for 3 days at 30°C. 
Diploids of bait/prey plasmid giving positive β-galactosidase activity on –Trp, -Leu 
ampicillin plates and negative β-galactosidase activity with corresponding LexA-lamin 
diploids are selected as potential interactors. They are stored at 4°C for not more 
than two weeks to avoid formation of spores following meiosis in conditions of limited 
nitrogen. 
 
4.2.2.8    Extraction of library plasmids from diploids and analysis  
 
Before bait plasmid extraction diploids are first perched to eliminate the bait plasmid 
by repeated growth on +Trp culture medium.  
Single colonies are grown in 5ml +Trp, -Leu medium overnight at 30°C with shaking. 
Cells are harvested at 2,500rpm for 5 min, re-suspended in 0.3ml of yeast lysis buffer 
and transferred into 1.5ml tubes. A volume of 150µl glass beads and 0.3ml of 
phenol/chloroform (1:1) are added taking care to remove all glass beads adhering 
near the top of the tube as they can be caught when the lead is closed and cause 
leakage of toxic phenol.  The tube is vigorously agitated for 3 min and centrifuged at 
1,400rpm for 1 min. The aqueous phase is transferred into a fresh 1.5ml tube and 
plasmid DNA precipitated with 0.1 volume 3 M sodium acetate and 1.5 volume of 
ethanol. The precipitate is dissolved in 25µl TE buffer and used for transformation of 
chemically competent E.coli strain JM109. Plasmid minipreps are made and 
sequenced using the M13 universal primers. Sequences are blasted against the 
NCBI data bank and potential binding partners selected based on their nuclear 
localisation and known role in embryonic development.   
 
4.3      Cell culture methods 
 
4.3.1     Cell culture and transfection 
 
Addition of CaCl2 and DNA into a buffered saline/phosphate solution containing 
cultured eukaryotic cells generates a CaPO4/DNA co-precipitate can be taken-up by 
the cells via endocytosis or phagocytosis (Gorman et al., 1985). 
Human epithelial kidney (h293) or human cervix carcinoma cells (Hela) are routinely 
grown in 5ml Dulbecco’s modified Eagle’s medium (DMEM) containing 10% fetal calf 
serum in the presence of 7% CO2 at 37°C in 250ml tissue-culture flasks (Greiner). 
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One days prior to transfection, cells are trypsinised, seeded to semi-confluence in 
culture tubes and incubated at 37°C. 4h prior to transfection, the medium is 
exchanged with 5ml fresh complete medium.  Following medium change, cells are 
incubated further incubated at 37°C for 4h. The different plasmids are mixed with 
HEPES buffered saline pH7.21 and 2.5 M CaCl2 solution is added drop-wise. The 
mixture is incubated at RT for 30 min. so that co-precipitates of CaPO4/DNA should 
form. This mixture is added to the respective cells and incubated at 37°C for 4h. 
Following medium change, the cells are incubated at 37°C for 48h and harvested in 
1.5 ml PBS. 450µl are saved to be used for luciferase assay and 900µl saved to be 
used for β-galactosidase assay. For analysis of the glucocorticoid response 
transfected cells are treated with various concentrations of dexamethasone while for 
analysis of the androgen response, cells are incubated with 10 nM 
dihydoroxytestosterone (DHT). 
 
4.3.2     Luciferase assay 
 
The luciferase assay is based on the principle that a luciferase reporter gene under 
the control of a defined promoter is expressed when the promoter is specifically 
activated. The expressed luciferase enzyme then transforms its substrate, Luciferin, 
to oxyluciferin with the emission of light at a particular wavelength which can be 
measured with a luminometer.  
Cells saved as 450µl samples are centrifuged at 5,000prm at 4°C for 5 min. and re-
suspended in 125µl Luciferase assay lysis buffer.  The extract is passed through a 
narrow gage syringe to facilitate cell lysis. To 20µl of the extract 100µl of luciferase 
assay substrate are added. Light emission is quantified as relative light units (RLU) in 
a luminometer (Berthhold Technologies). 
  
4.3.3    β-Galactosidase assay 
 
Cells saved in aliquots of 950µl in PBS are centrifuged at 5000prm at 4°C for 5 min 
and pellet re-suspended in 150µl 0.25 M Tris pH 7.8 and passed through a narrow 
gage syringe to facilitate cell lysis. To 60µl of each extract are added 6µl of 0.1 M 
MgSO4/4.5 M β-mercaptoethanol solution, 132µl of o-Nitrophenyl-β-glucopyranoside 
(ONGP), 402µl 0.1M sodium phosphate buffer pH 7.5. A similar sample is prepared 
but without cell extract to serve as negative control. Samples are incubated at 37°C 
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for 30 min to obtain the light yellow colour of the reaction product. Reactions are 
stopped by adding 1 ml of 1 M Na2CO3 and OD420 measured. 
 
4.3.4    Immunocytochemistry  
 
In a 6-well culture plate, three cover slides are introduced and coated with a drop of 
Alzian blue per slide for 15 min at RT.  Excess die is removed by exhaustive 
exchanging the die with DMEM medium containing 10% fetal calf serum. 2.5 ml of 
tripsinised human cervix carcinoma (Hela) cells are then seeded in each well and 
incubated at 24°C and 7% CO2. Cover slides are then removed and washed with 3x 
10 min changes of APBS/ 2mM CaCl2. The cell are fixed with 10% paraformaldehyde 
in APBS/ 2mM CaCl2 for 10 min and intracellular proteins denatured in 10% Triton in 
APBS/ 2mM CaCl2 for 8 min. Unbound protein sites on the cover slides are blocked 
with 1%BSA in APBS/ 2mM CaCl2 for 30 min and washed with 3x 10 min. changes of 
APBS/ 2mM CaCl2. Slides are then placed in the anti-Tcf-3/Tcf-4 or anti-Hic-5 
primary antibody overnight at 4°C. After 3x 10 min. washes, slides are placed in Goat 
anti-mouse secondary antibody coupled to Cy3 for 2h at RT. Slides are washed and 
observed in a drop of elvanol under the fluorescence microscope.    
 
4.4   Developmental Biology methods 
 
4.4.1  Induction of egg maturation  
 
Human choriongonadotropin (HCG) hormone induces egg maturation in Xenoups 
within 14-18h.  
The dorsal lymph sacs of Xenopus laevis adult females are injected with 50U of HCG 
hormone and after 14-18 h another hormone dose of 600U is given. After about 6-8h 
the eggs are gently squeezed out manually from the oviducts of the frog and 
collected in a Petri dish. Subsequent squeezing can be done after every 1 hour for a 
maximum number of 4 batches. 
 
4.4.2    Extraction of the Testes 
 
A male frog is anesthetized by placing it in fumes of a 0.05% (v/v) amino-benzoic 
acid-ethylestermethane solution for 30 minutes. Using a sharp blade the urino-
genetal system is exposed and the testes are observed as orange coloured bodies 
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lying ventral to the kidneys. These testes are isolated and stores in 1x MBSH solution 
at 4°C for a maximum of 4 days.  
 
4.4.3   In-vitro fertilization 
 
A piece of testis is macerated in 1-1.5 ml 1x MBSH. 100-200µl of this testis stock 
suspension is diluted to 0.1x MBSH and distributed over the squeezed eggs. About 
30 min later, the Petri dish is filled with 0.1x MBSH and kept at 14-16°C. Success of 
fertilization is determined by the upward turning of the pigmented animal pole. 
Approximately 90-120 min. after fertilization, the embryos start to cleave. The jelly 
coat is then removed by gently spinning the embryos in 2% cysteine solution pH 8.0 
for 2 min. Afterwards the eggs are intensively rinsed with 0.1x MBSH to remove 
excess cysteine.  
 
4.4.4      Microinjections 
 
The glass needle is fixed onto a micromanipulator that is connected to an air pump. 
The injection volume is determined by measuring the diameter of a water droplet 
expelled into mineral oil from the glass needle tip using a standard square meter. For 
injection the embryos are transferred into an agarose-coated dish containing 0.1x 
MBSH and fixed in the wells by gently eliminating the buffer. Messenger RNA is 
injected in a volume of 4-10 nl into the two ventral blastomeres of 4-cell stage 
Xenopus laevis embryos. Dorsal and ventral blastomeres can be distinguished at the 
4-cell stage by their size and pigmentation: dorsal blastomeres being less pigmented 
and smaller than ventral ones. After injection, the embryos are kept in 1x MBSH for 
about 1-1.5 hours at RT for wound to heal and then cultured in 0.1x MBSH at 14-
18°C. 
 
4.4.5    Analysis of embryos 
 
Embryos are sorted out under the light microscope for any eventual phenotype and 
statistical data collected. 
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5.    Results 
 
5.1    Cloning of GST fusions of Xenopus Lef/Tcf Transcription factors 
 
In order to identify novel binding partners, a method of choice is the use of 
recombinant proteins incubated with crude cell lysates followed by identification of 
bound protein on SDS PAGE gel and analysis by MALDI-TOF. A prerequisite for 
these studies is to isolate large quantities of highly purified fusion proteins. Thus, the 
core domain of Xenopus Lef-1 (aa63-aa274,), XTcf-3 (aa63-aa328) and XTcf-4 (aa63-
aa353) as well as the activating exons of XTcf-3 (aa193-aa249) and XTcf-4 (aa220-aa316) 
in XLef/Tcfs were inserted into XhoI/NcoI site of the pETM-30 expression vector (Fig. 
10).  
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Fig. 11: Restriction analysis of the core domain of transcription factors in pETM-30 vector 
with XhoI and NcoI. The core domain of XLef-1 (lane 1), XTcf-3 (lane 2), XTcf-4A (lane 3) 
and XTcf-4B respectively were excised from the pETM-30 vector with XhoI and NcoI 
enzymes and analysed on a 1% agarose gel. The 2-log molecular weight marker (M) with 
molecular weight of most intense bands is indicated. 
 
Similarly, the Domain A of Lef-1 (aa67-aa213), XTcf-3 (aa63-aa221) and XTcf-4C (aa63-
aa260) were cloned into the XhoI site of pET41b expression vector respectively. 
Lef/Tcfs cloned in pET vectors allows high-level purification and tandem affinity 
purification via His and GST tags.  
 
5.2     Induction of GST-fusions proteins 
 
GST-fusion constructs of Xenopus Lef/Tcf were used to transform bacterial strain 
BL21 DE3 and induced with 1.0 mM IPTG. Cell lysates were analysed on a 10% SDS 
PAGE gel. A gel sample of the results for the induction of Lef/Tcf core domain fusions 
and the control vector is shown on Fig. 12A with the induced bands corresponding to 
the most intense band of each lane. The sizes of the fusion proteins correspond to 
those predicted, for XLef-1 55 kD, XTcf-3, 60 kDa, XTcf-4 65 kD and the DCOH-GST 
fusion about 40 kD. Apart from these prominent bands, other bands although faint 
were observed on the gel. These faint bands represent either the bacterial proteins or 
degradation products of the fusion proteins.  
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293 cells which served as a protein pool.  These cells were chosen because 
sequence data (peptide mass data) for human proteins is available and the 
XLef/XTcf functional diversity was established using these cells (Gradl et al., 2002a). 
Subtype-specific binding partners should be present in these cells.  Following several 
washing steps the bound proteins were eluted with sample buffer and analysed on a 
10% or 12% SDS PAGE gel. Gels were stained with Coomassie blue dye (Fig. 13A) 
or Silver (Fig. 13B).  
The binding of the Lef/Tcf fusion proteins on the sepharose gel was efficient and this 
is testified by the presence of a strong band on each lane having the right molecular 
weight on the SDS PAGE gel. Faint bands existing in both the control and the test 
samples correspond to either bacterial proteins that bound to the sepharose gel or 
they represent degradation products from the fusion protein. In addition to these 
bacterial impurities and the degradation products the other faint bands in the samples 
incubated with lysates of transfected cells should correspond to the putative Lef/Tcf 
binding partners. 
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proteins were eluted from the gel, digested with trypsin and analysed by MALDI TOF.  
Results revealed proteins such as F1 ATPase, ribosomal proteins and many others 
which were all of cytoplasmic and mitochondrial localization. None of these proteins 
were described to be involved in early development and there was no indications that 
any of them could shuttle into the nucleus where the Lef/Tcfs transduce Wnt/β-
catenin signals.  Purification of Lef/Tcf proteins on Nickel nitriloactetic acid (Ni-NTA) 
columns prior to binding and improvement of elution conditions did not improve the 
pull-down. Drawbacks encountered with the bacterial expression system imposed a 
switch in procedure to a yeast two-hybrid system that circumvents the problem of 
protein impurities and degradation.  
 
5.4      Yeast two-hybrid screen. 
 
5.4.1   XLef-1 and not XTcf-3 and XTcf-4 independently activates the β- 
           galactosidase reporter 
 
Since the read-out of the two-hybrid system makes use of a transcription event, one 
of the most crucial initial experiments is to check whether the bait alone is able to 
initiate transcription independent of the prey. To exclude the latter, the core domain 
of XLef-1 (aa63-aa274,) was inserted into the Bam HI/PstI, while XTcf-3 (aa63-aa328)  
and XTcf-4 (aa63-aa353) were inserted into the EcoRI/SalI sites of the BTM116 vector 
in frame with the DNA binding domain of LexA (Fig. 14). Correct insertion was 
verified by restriction digestion and sequencing. 
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Fig. 14: BTM116 plasmid carrying the LexA DNA binding
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To be certain that these constructs do not independently activate the reporter gene, 
they were assayed for Lac-Z activation by β-galactosidase test. This assay revealed 
that LexA-XLef-1 fusion proteins activated the β-galactosidase gene independent of a 
prey (blue colour of β-galactosidase). In contrast, LexA-XTcf-3 and LexA-XTcf-4 
fusion proteins did not activate the transcription of the β-galactosidase gene 
(absence of blue colour) (Fig.15).  
      LexA-XLef-1                           LexA-XTcf-3                     LexA-XTcf-4C 
 
  L40  
 
 
 
Fig. 15: LexA-XLef-1 construct independently activates the β-Galactosidase promoter 
(Blue colour of β-Galactosidase). Yeast strain L40 were transformed with LexA-XLef-1 
LexA-XTcf-3 and LexA-XTcf-4 construct in BTM116 vector and transformats were assayed 
for β-galactosidase activity. Whereas LexA-XLef-1 activates the Lac-Z promoter (presence of 
blue colour of X-gal product), LexAXTcf-3 and LexA-XTcf-4 do not independently activate 
the promoter (absence of blue colour). 
 
This ability of LexA-Lef-1 to activate transcription independently of the prey made it 
useless as bait. The inability of LexA-XTcf-3 and LexA-XTcf-4 to activate transcription 
qualifies them for use as baits in the yeast two-hybrid screen.  
 
5.4.2     Numerous library proteins interact with the core domains of XTcf-3  
             and XTcf-4  
 
To identify proteins interacting with XTcf-3 and XTcf-4 core domains, L40 yeast strain 
previously transformed respectively with LexA fusion constructs in BTM116 vector 
were further transformed with the mouse embryonic day 10 cDNA library. This library 
was kindly provided by Jürgen Behrens. The mouse library was used because no 
Xenopus library adapted for yeast two hybrid system was available. Moreover, this 
mouse library had previously been used to isolate authentic binding partners of β-
catenin such as Lef-1 and conductin (Behrens et al., 1996 and 1998).   
Many proteins of the library interacted with the core region of XTcf-3 and XTcf-4 
since many colonies grew on selective medium and possessed β-galactosidade 
activity (Fig. 16). 
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Table 2: Potential interacting partners of XTcf-3. The subcellular localization and the roles 
played by each of these partners in the cell are indicated. The asterisk (∗) indicates clones 
obtained more than once in the screen. 
 
Protein Localization Role 
LITAF 
(Lipopolysaccharid
e-induced TNF-α 
factor)  
Placenta, Lymphoid 
organs. 
(Nucleus) 
Binds to human tumour necrosis factor 
(hTNF)-α promoter and regulates its 
transcription and thus regulates the 
inflammatory effect of TNF-α (Tang et al., 
2003) 
Ror 2  
(Retinoic acid 
orphan receptor 2) 
∗ 
Transmembrane  Involved in skeletal and cardiac development. 
Mutants lead to septal and respiratory defects 
resulting to neonatal lethality (Nomi et al., 
2001).  
Dlxin1∗ Nucleus/Cytoplasm Nucleus: Binds to genes involved in skeletal 
development and regulate their transcription 
(Masuda et al., 2001).  
Cytoplasm : sequested by binding to 
cytoplasmic tail of Ror2 (Matsuda et al., 
2003) 
TOLLIP (Toll-
interacting protein) 
Cytoplasm. Binds to the cytoplasmic tail of Toll-like 
receptors and may be involved in control of 
the inflammatory effects of TNF-α. (Moynagh, 
2003). 
 
Table 3: List of potential interacting partners of XTcf-4. The corresponding subcellular 
localization and the roles played by each of these partners in the cell are indicated. The 
asterisk (∗) indicates clones obtained more than once in the screen.   
 
Protein Localization Role 
Hic-5  
(Hydrogen 
peroxide.-inducible 
clone 5) or 
Androgen 
Receptor Activator 
(ARA 55) 
Nucleus and at focal 
adhesion sites of cells. 
Nucleus: Binds to androgen receptors and 
participates in hormone-regulated of 
transcription (Fujimoto et al., 1999). 
Focal adhesions: Binds to focal contacts 
(Shibanuma et al., 2003). 
Dlxin1∗ Nucleus/Cytoplasm. Mentioned already in table 2 
ARC 105  
(Activated 
Recruited cofactor 
105)./ TIG-1 / 
Glutamine-rich 
transcriptional 
adaptor protein 
Cytoplasm. Induces axis duplication, morphogenic 
elongation and mesoderm differentiation. 
(Induces Xbra, chordin, mixer, goosecoid, 
xwnt8 and xnr4. but not Xnr3. Suppresses 
ventral markers: vent-1 and vent-2. Binds to 
smad2/3-4 in response to TGF-β and not 
samd1-4 of the BMP pathway (Kato et al.,  
2000). 
RNF4 Nucleus and cytoplasm of 
cells of developing 
nervous and reproductive 
systems. 
Promotes the formation of intra-cytoplasmic 
complexes involved in shuttling between the 
cytoplasm and the nucleus  (Galili et al., 
2000). 
MBP1 
Mutant-binding 
protein-1 (Fibulin4) 
Extracellular and nucleus. Binds to p53 protein and enhances tumour cell 
growth (Gallagher et al., 1998). 
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5.4.4     Confirmation of the putative interacting partners by GST pull-down  
              assays 
 
In order to confirm the yeast two-hybrid screen results, GST pull-down assays were 
carried out. In vitro translated 35S-labelled constructs of mouse RNF-4, ARC-105, 
MBP-1, TOLLIP, ROR2 and DLXIN were incubated with immobilized GST-fusions of 
the core domains of XLef/Tcfs. Bound proteins were separated on 10 % SDS PAGE 
gel, exposed to the phosphoimaging plate and analyzed for specific Lef/Tcf sub-type 
interaction using a phosphoimager (Fig. 19A). Whereas RNF-4 binds neither to the 
GST control nor the Lef/Tcfs, ARC105 and ROR2 bind to both the GST control and 
all the Lef/Tcf fusions. TOLLIP and DLXIN discriminated between the GST control 
and the Lef/Tcfs. Although TOLLIP and DLXIN bind to GST control, the signal with 
Lef/Tcfs are much more intense. Both proteins seem to bind preferentially to XTcf-3 
and XTcf-4A/B and less to XLef-1. However, further tests are required to confirm 
these two proteins as potential binding partners. MBP-1 does not bind to the GST 
control but binds to XLef-1 and even better to XTcf-3 and XTcf-4A/B. Interaction of 
Hic-5 with the Lef/Tcfs was investigated by Western blotting crude lyastes from 
human kidney epithelial (h293) cells transfected with myc-tagged versions of 
XLef/Tcfs. The cells were incubated with immobilised recombinant Hic-5. Bound 
Lef/Tcfs were detected with anti-myc antibody. Hic-5 neither binds to the GST control 
nor to XLef-1 but binds strongly to XTcf-3 and XTcf-4A/B (Fig. 19B). 
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verify this interaction. Using degenerate primers, a 510 bp fragment of XHic-5 was 
amplified and inserted into the pGEMT cloning vector. This 510 bp fragment was 
amplified by PCR and labelled with [α-32P]-dCTP and used as a probe to screen a 
Xenopus tadpole stage λ-zap cDNA library. Radioactive signals indicating to 
hybridisation of the probe to the target DNA were detected as black spots by the 
phosphoimager (Fig. 20).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 20: Xenopus 510 bp fragment binds to a complementary strand in the Xenopus tad 
pole stage library: E. coli XL-1Blue cells were transformed with the Xenopus tadpole stage 
library and plaque lifts were hybridised with a 510 bp Xenopus fragment labelled with [α-
32P]-dCTP. Radioactive signals corresponding positive clones. 
 
A 3.4 kb XHic-5 cDNA was isolated (Acc. No. AY971603) and this clone consisted of 
an open reading frame of about 1.3 kbp and a 2.1 kbp 3´untranslated sequence. The 
deduced amino acid sequence of XHic-5 protein contains 459 aa (Fig. 21) with a 
predicted molecular weight of about 52 kD.   
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ACT AAA GGG AAC AAA AGC TGG AGC TCC ACC GCG GTG GCG GCC GCT CTA GAA CTA GTG GAT CCC CCG GGC TGC AGG AAT TCG GCA  
CGA GAT GCA CTA CTC GCT GAC CTC CAA ATC ACG ACC ACT CCA CGT TGT CCA GTT TTA CTA ACA GAT TCT CCT GAG AAA CCT CAG  
 
                                                            M   S   N   T   T   S   H   H   E   T   F   P    
CCT GCT GAG ACT CGA CCT CCT CCA CCG CCC TAC GAT CCC AAG ACT GCA ATG TCG AAT ACG ACG TCC CAC CAT GAG ACC TTT CCA  
 
 V   D   K   D   H   L   Y   S   T   V   Q   K   Y   P   L   P   S   V   S   P   A   L   G   G   G   L   C   E 
GTG GAC AAG GAC CAT CTC TAT AGC ACT GTA CAG AAA TAT CCT TTG CCT TCT GTC TCG CCA GCC TTG GGT GGT GGG CTG TGT GAA 
 
 L   D   R   L   L   N   E   L   N   A   T   Q   F   N   I   T   D   E   I   M   S   Q   F   P   T   R   D   P 
TTG GAC CGA CTT CTC AAT GAA CTC AAC GCC ACA CAA TTC AAC ATC ACT GAT GAG ATA ATG TCC CAG TTC CCT ACT CGG GAT CCC 
  
 N   E   Q   K   A   E   A   Q   K   E   A   E   K   R   A   L   A   A   S   S   A   T   L   E   L   D   R   L 
AAT GAA CAG AAA GCT GAA GCA CAG AAA GAG GCA GAG AAA AGG GCC CTC GCT GCC TCC TCT GCC ACT CTT GAG TTG GAC CGC CTG 
  
 M   A   S   L   S   D   F   H   K   Q   N   T   V   S   Q   E   G   E   V   P   D   S   N   K   G   S   E   E 
ATG GCT TCC CTG TCT GAT TTC CAC AAG CAG AAC ACG GTA TCA CAA GAA GGG GAG GTT CCT GAC TCT AAT AAA GGC TCT GAG GAA 
 
 V   F   K   P   R   D   T   E   D   P   S   S   P   R   D   T   L   D   V   P   K   A   L   E   D   I   P   S 
GTT TTC AAA CCT AGA GAT ACA GAA GAC CCA TCA AGC CCT AGA GAC ACA CTT GAT GTT CCT AAA GCT TTG GAG GAC ATA CCA AGT 
  
 P   K   S   S   E   V   M   S   T   P   G   H   M   E   V   K   I   D   Q   V   N   S   D   K   V   T   A   S 
CCT AAA AGT TCT GAG GTG ATG TCC ACC CCT GGG CAT ATG GAA GTC AAA ATC GAC CAA GTA AAT TCT GAT AAA GTA ACA GCT TCC 
  
 R   L   P   D   S   V   S   G   S   K   V   P   E   A   T   S   V   P   R   S   D   L   D   S   M   L   V   K 
CGG TTG CCT GAC TCT GTG TCT GGT TCC AAA GTT CCA GAA GCC ACA AGT GTT CCA AGG AGT GAT CTG GAC TCC ATG CTG GTA AAG 
 
 L   Q   S   G   L   K   Q   Q   G   I   E   T   H   S   K   G   L   C   E   S   C   Q   R   P   I   A   G   Q    
CTA CAG TCT GGG CTC AAG CAA CAA GGC ATT GAA ACG CAC AGC AAG GGA CTG TGT GAG AGC TGC CAA CGA CCT ATA GCC GGG CAG 
  
 V   V   T   A   L   G   H   T   W   H   P   E   H   F   V   C   A   H   C   H   A   L   I   G   T   S   N   F 
GTG GTT ACT GCT CTT GGA CAT ACC TGG CAC CCG GAG CAC TTT GTG TGT GCC CAC TGC CAT GCC CTG ATT GGC ACT TCC AAC TTC 
  
 F   E   K   D   G   R   P   Y   C   E   K   D   Y   F   M   L   Y   A   P   R   C   A   L   C   D   L   P   I 
TTT GAG AAG GAC GGA CGG CCA TAT TGC GAG AAA GAC TAC TTT ATG CTC TAC GCC CCA CGC TGT GCC CTG TGT GAC TTG CCA ATT  
  
 V   Q   N   M   V   T   A   L   G   R   T   W   H   P   E   H   F   C   C   K   I   C   K   K   P   I   G   E 
GTG CAG AAC ATG GTT ACG GCA CTT GGT CGC ACT TGG CAC CCA GAG CAT TTT TGT TGT AAA ATC TGC AAA AAA CCG ATA GGG GAA 
  
 E   G   F   H   E   K   D   G   E   Q   Y   C   S   D   D   Y   F   R   L   F   G   A   V   C   A   G   C   T 
GAG GGT TTC CAT GAG AAG GAT GGG GAA CAG TAT TGC TCA GAC GAC TAT TTC CGG CTG TTT GGA GCT GTC TGT GCA GGC TGC ACT 
  
 E   A   V   K   E   S   Y   I   S   A   L   G   G   L   W   H   P   Q   C   F   V   C   H   V   C   H   T   P 
GAG GCC GTG AAG GAG AGT TAT ATC TCT GCC CTG GGA GGC TTG TGG CAC CCA CAA TGC TTT GTG TGT CAT GTG TGT CAC ACA CCA 
  
 F   I   N   G   S   F   F   E   H   E   G   L   P   L   C   E   T   H   Y   H   S   R   R   G   S   L   C   A 
TTC ATC AAT GGA AGT TTC TTT GAA CAT GAA GGC TTA CCT CTA TGT GAG ACT CAT TAC CAC TCT CGT CGT GGC TCG CTG TGT GCT  
  
 G   C   E   Q   P   I   T   G   R   C   V   A   A   M   G   K   K   F   H   P   Q   H   L   S   C   T   F   C    
GGG TGT GAG CAG CCA ATA ACA GGG CGC TGC GTG GCT GCA ATG GGC AAG AAG TTC CAC CCC CAA CAC TTG AGT TGC ACT TTT TGC  
 
 L   R   Q   L   N   K   G   T   F   R   E   H   D   G   K   P   Y   C   Q   A   C   Y   A   R   L   Y   G 
CTC CGA CAG CTG AAC AAG GGC ACC TTC CGG GAG CAT GAT GGG AAA CCT TAC TGC CAG GCT TGC TAC GCC CGA CTG TAT GGG TAG  
 
GGC AGT TAG ATG GTT TCA GGA AAG GAG GGT CAT CTG AAA TAT CAA GCT TCA CAA AGA CTA TAC AAA GGA TGT TGT GCA AGG CAC  
CAG ATT GCA AGG CTC TGC AAG GGA AAG GGC TGG CTG CTC TGA AGG TCA CAC AAA ATG CAC TGC TCA TCC AGC TCT GCA AGA ATC  
CAC GTG CAA TTT TTT CTG CAG GGA AAT GGG CTA AAA GCT TTT GGT TTT GTA CGT GAA CAC ATG CAT GTA AGG TCA AAT GGA GAA  
GGT GAC ATC TGC TCT GCA AAC CCC TTG GGC ATC ACA TTA ACT GGT CTT ATG GAA AGG AGC CAG CTG CTC TGC AAG CTT TGT GCA  
GAG TTC TAC AAT ATA AAA CAG CTG CTG TGC ACA CAC TCC AAG GCT ATG TGC AAA GTT TGT CAA GGA GAC TGA TCT CCA AGC CGT  
CTG AGA TCA AGA CAA AGT GCA AAA TTG TGT GGA GGC GTC TGC TCT GCA ACC TTC TGA GAC TAA GTG CAA AAT TGT GCA AGG TTG  
GAG TCA GCG AAA CTA TAG AGG AAG CAG ACC GTG CAG CTG CAG GGG GGC CCA GGA AAT ATA GGG GGC CCC AAG AGG CTC TAA TTC  
ATA TAC AAT TTC AGT AAA TAT TGG TAA AAC AGG ACA ACC TCT GGA TAT GTT GGG GGC CCT AAA ACT AAT TTG CTG TGG GGC CCA  
GTA ACA TCT AGT TAC GCC ACT GAG AGG GGA CAT CTG CTC TGC CAA ACC TTC TGA GGC AAA GTG CAA AGT TCT GCA AGG GAG GAG  
CCA GCT GCT CTG TAA ACC TTC TGA GAC AAA GTG CAA AGT TCT GCA GGG AGG AAC CAG CTG CTT TGC AAA CCT TCT GAG ACA AAG  
TGC AAA GTT CTG CCA GGG AAG GAG CCA TCT TCT NTG CAA ACC TTC TGA GAC TAA GTG CAA CAT TCT GCA AGG GAG GAA CCA TCT  
GTT CTG CAA ACC TTC TGA GAC TAA GTT CAA AGT TCT GCA AGG GAG GAG ACA TCT GCT CTG CAA ACC TTC TGA GAT TAA GTG CAC  
AGT TCT ACA AGG GAT GAG CCA GCT GCT CTG CAA ACC TTC TGA GAC AAA GTG CAA AAT TCT GCA AGG GAG GAG ACA TCT GCT CTG  
CAA ATC TTC TGA AAC TAA GTA CAA AGT TCA GCA AGG AAG GAG ACA TCT GCT TTG CAA ACC TTC TGA GAC AAA GTG CAA AGT TCT  
GCA AGG AAG GAG CCA TCT GCT CTG CAA ACC TTC TGA GAG TAA GTG CAA CAT TCT GCA AGG GAG GAA CCA TCT TTT CTG CAA ACC  
TTC TGA GAC TAA GTT CAA AGT TCT GCA AGG GAG GAG ACA TCT GCT CTG CAA ACC TTC TGA GAT TAA GTG CAC AGT TCT ATA AGG  
GAT GAG CCA GCT GCT CTG CAA ACC TTC TGA AAC TAA GTA CAA AGT TCT GCA AGG AAG GAG ACA TTG CTC AGC AAA CCT TCT GAG  
ACT AAG TGC AAT GTT CTG CAA GGG AGG AAC CAT CTG TTC TGC AAA CCT TCT GAG ACT AAG TGC AAA GTT CTG CAA GGG AGG AAC  
CAC CTG TTC TGC AAA CCT TCT GAG ACT AAG TGC AAA GTT CTG CAA GGG AGA AGC CAG CTA CTC TGC AAA CCA TCT GAG ATG GAG  
CAA AAA GAG CTA CTA TGC ATT CAT TGG TCA GCT TTC TAA AAC CAA ACA TAT GAT TGG TCA CAG AGT TTC TGC ATA AGC CTG AGA  
GTA TTT TTA CAC ACA TCC AAT TAA AAA GGG CAT TGT AAT CAC AGT TGT AGG GTT GCT CCA TGT CTA GTA ACC CAT AGC AAC CAA  
 
Fig. 21: The isolated Xenopus Hic-5 DNA has an open reading frame of 1.3 kbp and 2.1 
kbp 3´ untranslated sequence. The deduced amino acid sequence of XHic-5 protein is 
represented. 
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Full length Hic-5 protein is 40% identical to its human orthologue. The similarity in the 
conserved three LD and four Lim domains ranges from 55% (LIM-2) to 100% (LD-2) 
(Fig. 22). 
 
Xhic-5 MSNTTSHHETFPV________________________DKDHLYSTVQKY___________PLPSVSPALG        
hhic-5 MPRSGAPKERPAEPLTPPPSYGHQPQTGSGESSGASGDKDHLYSTVCKPRSPKPAAPAAPPFSSSSGVLG        
mhic-5 MSRLGAPKERPPETLTPPPPYGHQPQTGSGESSGTTGDKDHLYSTVCKPRSPKPVAPVAPPFSSSSGVLG        
 
           LD-1                 
Xhic-5 GGLCELDRLLNELNATQFNITDEIMSQFPTRDPN__EQKAEAQKEAEKR____________ALAASSATL 
hhic-5 TGLCELDRLLQELNATQFNITDEIMSQFPSSKVASGEQK_EDQSEDKKRPSLPSSPSPGLPKASATSATL 
mhic-5 NGLCELDRLLQELNATQFNITDEIMSQFPSSKMAEGEEK_EDQSEDKSSPTVPPSPFPAPSKPSATSATQ 
 
           LD-2      
Xhic-5 ELDRLMASLSDFHKQNTVSQEGEVPDSNKGSEEVFKPRDTEDPSSPRDTLDVPKALEDIPSPKSSEVMST 
hhic-5 ELDRLMASLSDFRVQN______HLPASG____________________________PTQPPVVSSTNEGS 
mhic-5 ELDRLMASLSDFRVQN______HLPASG____________________________PPQPPAASPTREGC 
 
                                                LD-3 
Xhic-5 PGHMEVKIDQVNSDKVTASRLPDSVSGSKVPEATSVPRSDLDSMLVKLQSGLKQQGIETHSKGLCESCQR 
hhic-5 PSP___________________________PEPTGKG_S_LDTMLGLLQSDLSRRGVPTQAKGLCGSCNK 
mhic-5 PSP___________________________PGQTSKG_S_LDTMLGLLQSDLSRRGVPTQAKGLCGSCNK 
 
                           LIM-1 
Xhic-5 PIAGQVVTALGHTWHPEHFVCAHCHALIGTSNFFEKDGRPYCEKDYFMLYAPRCALCDLPIVQNMVTALG 
hhic-5 PIAGQVVTALGRAWHPEHFVCGGCSTALGGSSFFEKDGAPFCPECYFERFSPRCGFCNQPIRHKMVTALG 
mhic-5 PIAGQVVTALGRAWHPEHFLCSGCSTTLGGSSFFEKDGAPFCPECYFERFSPRCGFCNQPIRHKMVTALG 
 
                      LIM-2                                            LIM-3 
Xhic-5 RTWHPEHFCCKICKKPIGEEGFHEKDGEQYCSDDYFRLFGAVCAGCTEAVKESYISALGGLWHPQCFVCH 
hhic-5 THWHPEHFCCVSCGEPFGDEGFHEREGRPYCRRDFLQLFAPRCQGCQGPILDNYISALSALWHPDCFVCR 
mhic-5 THWHPEHFCCVSCGEPFGEEGFHEREGRPYCRRDFLQLFAPRCQGCQGPILDNYISALSALWHPDCFVCR 
                                                                        
                                                                       LIM-4 
Xhic-5 VCHTPFINGSFFEHEGLPLCETHYHSRRGSLCAGCEQPITGRCVAAMGKKFHPQHLSCTFCLRQLNKGTF 
hhic-5 ECFAPFSGGSFFEHEGRPLCENHFHARRGSLCATCGLPVTGRCVSALGRRFHPDHFTCTFCLRPLTKGSF 
mhic-5 ECLAPFSGGSFFEHEGRPLCENHFHAQRGSLCATCGLPVTGRCVSALGRRFHPDHFTCTFCLRPLTKGSF 
 
 
Xhic-5 REHDGKPYCQACYARLYG 
hhic-5 QERAGKPYCQPCFLKLFG 
mhic-5 QERASKPYCQPCFLKLFG 
 
 
Fig. 22: Protein alignment of Xhic-5 with its human and murine orthologues reveals high 
homology in the LD- and LIM- domains. The three LD motives are indicated in violet and 
the four LIM domains are illustrated by blue bars.  
  
The most obvious differences between the mammalian and the Xenopus Hic-5 
proteins is the absence of two proline-rich streches of 24 and 11aa respectively 
which flank a highly conserved region of of 11aa in the Xenopus protein. Conversely, 
XHic-5 possesses two acidic and serine-rich stretches of 28 and 27 aa between LD-2 
and LD-3 which are absent in the human and murine orthologues (Fig. 22).  
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5.6 Xenopus Hic-5 discriminates between XTcf-3 and XTcf-4 and XLef-1 
 
Bacterially expressed GST-Lef/Tcf fusion proteins were incubated with in vitro-
translated 35S-labelled or transfected myc-tagged Xhic-5 and bound proteins were 
separated on an SDS PAGE gel.  
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Fig. 23: Xhic-5 binds to Xenopus Tcf-3 and Tcf
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GST control and XLef-1 core region was detected while strong binding was observed 
to XTcf-3 and XTcf-4 core regions (Fig. 23A). Similar results were obtained when 
bound proteins from kidney epithelial cells transfected with myc-tagged XHic-5 were 
probed with anti-myc epitope antibody. Whereas no binding of Hic-5 was observed 
for the GST control, binding to XLef-1 core region was very low while strong binding 
was detected for XTcf-3, XTcf-4 and XTcf-4B core regions (Fig. 23B). 
 
5.7 Hic-5 binds to the conserved Exon 
 
The most obvious difference between XLef-1 and Tcf-3 and -4 in the core region is 
the absence of an alternatively spliced activating Exon in XLef-1. Since Hic-5 binds to 
XTcf-3 and XTcf-4 but not XLef-1, this Exon might be the domain of interaction with 
Hic-5. To confirm this, a myc-tagged version of XLef-1 containing the Exon excised 
from XTcf-3 was used in GST pull-down assays. Whereas Hic-5 did not interact with 
XLef-1, it bound to XLef-1+Exon Fig. 24A).  
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5.8   The LIM domain-containing C-terminal half of Hic-5 binds to Lef/Tcfs  
 
To map the binding domain in Hic-5, GST fusions of the N-terminal half (GST-
mHic5∆C) containing the LD domains (aa1-aa202) and the C-terminal half (GST-
mHic5∆N) containing the LIM domains (aa212-aa430) were used in GST pull-down 
assays. Autoradiograph results revealed that all Tcfs that contain the conserved Exon 
(mLef-1, hTcf-3, hTcf-4, hTcf-1 and mTcf-3) but not XLef-1 interacted with the LIM 
domain-containing C-terminal half. Whereas binding of mLef-1 was very strong, the 
Tcfs interacted only weakly with the C-terminal half of Hic-5. In one case (hTcf-4) a 
very weak binding of the LD domain-containing N-terminal half was observed. In 
summary, Lef/Tcfs bind via a conserved Exon preferentially to the Lim domain-
containing C-terminal half of Hic-5 (Fig. 25).  
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ig. 25: Lef/Tcfs weakly bind to the LIM domain-containing C-terminal half of mHic-5. 
ecombinant C-terminal half (GST-Hic-5∆N, LIM domains, aa212-aa430) and N-terminal half 
ST-Hic5∆C, LD-domains, aa1-aa202) of mHic-5 were immobilized on glutathione sepharose 
nd incubated with in vitro translated 35S-labeled murine and human Lef/Tcfs. The upper 
anels show the autoradiograph. XLef1 served as a negative control and neither bound to the 
-terminal half nor the N-terminal half of mHic-5. The lower panels show the same gels 
ained with Coomassie blue to demonstrate equal loading.  
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5.9   Hic-5 represses Lef/Tcf-induced target gene promoter activation 
 
To investigate if the physical interaction between Lef/Tcfs and Hic-5 could modulate 
transcription of Wnt/β-catenin target genes, reporter gene assays were carried out in 
h293 cell co-transfected with Lef/Tcf reporter constructs, Hic-5, CMV-β-galactosidase 
(for normalization) and different Lef/Tcf expression constructs.  
 
5.9.1     Hic-5 represses TOPFlash promoter activation 
 
Mouse Hic-5 and Xenopus Hic-5 regulate Tcf optimal binding (TOPFlash) promoter in 
a similar manner. In the absence of Lef/Tcfs both murine and the Xenopus Hic-5 had 
insignificant effect on the activity of the TOPFlash promoter. XLef-1, XLef-1+Exon 
and XTcf-4C but not XTcf-4A and XTcf-3 significantly activate the TOPFlash 
promoter in h293 cells in the absence of Hic-5 (Fig. 26A) consistent with the fact that 
XLef-1 and XTcf-4C are general activators while XTcf-3 and XTcf-4 are repressors 
(Pukrop et al, 2001, Gradl et al., 2002). In the presence of Hic-5, however, XTcf-4C 
did not activate the TOPFlash promoter and the activation by the chimeric XLef-
1+Exon construct was drastically reduced. In the case of XTcf-4C, the promoter 
activation dropped from 2.1 fold to 1.2 (murine Hic-5) or 0.8 fold (Xhic-5), while for 
XLef-1+Exon fold activation dropped from 4.1 to 1.9 or 1.5, respectively. Activation 
via Hic-5 had no effect on TOPFlash activation via XLef-1. The promoter was 
activated 1.5 to 2 fold, irrespective to whether Hic-5 was co-transfected or not (Fig. 
26A). The mutated TOPFlash control promoter (FOPFlash) was neither activated by 
XLef-1+Exon nor repressed by Hic-5 (Fig. 26B). 
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.9.2     Hic-5 represses fibronectin promoter activation. 
egulation of Wnt target genes by Hic-5 was not restricted to the artificial TOPFlash 
romoter. Similar responses were observed with the Xenopus fibronectin promoter. 
gain, co-transfection of Hic-5 prevented promoter activation by XLef-1+Exon (1.7 
ld versus 3.2 fold) and XTcf-4C (1.6 fold versus 2.3 fold) but not by XLef-1 (1.9 
ersus 1.9) (Fig. 27). 
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f-3 is a strong repressor of Wnt/β-catenin target 
radl et al., 2002).  Hic-5 could not further repress it. 
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down-regulated following co-transfection of Hic-5 as revealed by RT-PCR analysis 
(Fig. 29B). 
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Fig. 29: Hic-5 represses Lef/Tcf-induced target gen
ventrally with 70 pg Xwnt-8 RNA revealed complete dor
by the appearance of a ring shaped cement gland. Co
resulted in a partial rescue and the appearance of second
the appearance of a single axis. B) Expression analysis 
Xnr-3 by RT-PCR in injected and uninjected stage 10
shows the amplification of the housekeeping gene histon
without reverse transcriptase. 
 
5.11 Lef/Tcfs regulate steroid receptors in a Hic
 
Hic-5 is known to be a co-activator of glucocorticoi
al., 2004) and androgen receptors (Fujimoto et al, 19
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whether Lef/Tcfs regulate Hic-5-mediated activation
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tumour virus (MMTV) long terminal repeat (LTR) in
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 human cervix carcinoma (Hela) 
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th Lef/Tcfs as revealed by double 
clonal anti-Lef-1 or Tcf-3/-4 (Fig. 
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s. 
MTV is a model promoter for studying steroid receptor activation, because it 
tes target gene expression in response to signals from steroid receptors 
corticoid, mineralcorticoid, progesterone and androgen receptors).    
1.    MMTV reporter responses to Dexamethaxone in a dose dependent  
       manner. 
 studying the influence of Lef/Tcf interaction with Hic-5 on MMTV response it is 
ary to determine the appropriate hormone concentration at which the 
orticoid receptor (GR) is sufficiently activated so that both activation and 
sion can be observed. Hela cells were therefore co-transfected with MMTV-
se and CMV-β-galactosidase (for normalization) and treated with different 
trations of dexamethasone. 
ter gene assay results reveal that MMTV promoter responds to the hormone in 
 dependent manner. Up to 1 nM dexamethasone activated the promoter about 
 10 nM approximately 9 fold and further increase to 20 nM resulted in over 15-
tivation (Fig. 31A). RT-PCR analysis revealed that this dose dependency was 
bserved at the level of the endogenous glucocorticoid target gene transcription. 
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Transcription of p21cip1 and p27kip1 genes was almost undetectable at 0 to 1 nM 
dexamethasone concentration but robustly increased at higher concentrations (Fig. 
31B). The moderate concentration of10 nM dexamethasone was chosen for 
subsequent assays. 
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 Dexa (nM)        0  0.1   1   10   20     
 
Fig. 31: MMTV reporter responses to dexamethaxone (Dexa) in a dose dependent manner. 
A) Hela cells were co-transfected with MMTV-Luciferase and CMV-β-galactosidase (for 
normalization) and treated with the indicated amounts of dexamethasone. Each bar represents 
the mean value of at least 7 transfections. The error bars indicate the standard error. B) RT-
PCR-analysis reveals that the expression of the glucocorticoid receptor target genes p21cip1 
and p27kip1 depends on the hormone concentration. GAPDH shows the amplification of a 
house keeping gene, -RT indicates the control amplification of the housekeeping gene without 
reverse transcription. 
 
As expected for a steroid recepto-coactivator, Hic-5 enhances reporter activation 
from 9 to about 20 fold in the absence of Lef/Tcfs, (Fig. 32A). Over expression of 
XLef-1 and XLef-1+ Exon did not affect reporter activation in the absence of Hic-5. 
Overexpression of XLef-1 also had no significant effect on promoter activation (fold 
activation remains at approximately 20) in the presence of Hic-5. Conversely, 
overexpression of XLef-1+ Exon resulted in a repression of promoter activity (fold 
activation drops from about 20 to 14.5) in the presence of Hic-5.   
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from 9 fold to about 5 fold. Again, this repression was more pronounced in the 
presence of Hic-5. 
The influence of the interaction between Hic-5 and Lef/Tcfs on the activity of Hic-5-
regulated glucocorticoid target gene transcription was investigated by RT-PCR. 
Results reveal that both p21cip1 and p27kip1 target genes which remain at endogenous 
levels are activated by Hic-5 but not by Tcf-4. In the presence of both hTcf-4 and 
mHic-5, the target genes are down-regulated (Fig. 33). 
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ess androgen receptor target genes in a Hic-5 dependent   
ression of the MMTV promoter by Lef/Tcfs is specific for the 
on or is a general mode of repression of steroid receptor 
e co-transfected with human androgen receptor (AR) since 
dogenously express the androgen receptor. The androgen 
ated by dihydroxytestosterone treatment. This hormone 
to about 5 fold while co-transfection of Hic-5 lead to a 10 fold 
c-5-indepenedent activation was observed for XLef-1 and the 
ef-1+Exon. Co-transfection of Hic-5 however discriminated 
 constructs (Fig. 34).  
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Fig. 34: Lef/Tcfs repress androgen receptor targ
Hela cells were co-transfected with MMTV-Luc
galactosidase for normalization and the indicated 
presence (+ Hic-5, black bars) or absence (- Hic
receptor was activated by adding 10 nM dihydroxy
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Whereas the combination of XLef-1 and Hic-5 
combination of XLef-1+Exon and Hic-5 activat
constructs alone. Over expression of XTcf-3 a
Hic-5.  
As a summary, Hic-5 binding to the conserve
Exon of XTcfs lead to repression of Hic-5
receptors and steroid receptor target genes. Th
Xlef-1 which lacks the Hic-5 binding site.  
 
5.12.1      MBP1 binds strongly to Domain A 
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Xenopus Lef/Tcf constructs either in the 
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tivation by DHT treatment normalized to 
resulted into an additive activation, the 
ed the promoter less than each of the 
nd XTcf-4 prevented AR activation via 
d activating and alternatively spliced 
-mediated activation of both steroid 
is repression is not observed with the 
of XTcf-3 and XTcf-4 but weakly to  
wn as fibulin 4 is one of the XTcf-4 
hybrid screen (Table 3 page 64). Its 
 tumour cell growth (Gallagher et al., 
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1998) and its isolation as a binding partner of XTcf-4 (present study) suggests that it 
might play a central role in Wnt/β-catenin-mediated tumour growth. It was confirmed 
by GST pull-down assays to bind strongly to the core domains of XTcf-3 and XTcf-4 
but weakly to XLef-1 (Fig. 19, page 66). Since binding was observed for both XLef-1 
and XTcfs, it was evident that the Exon alone could not account for the recruitment of 
MBP1. Therefore, in order to further characterize this binding partner, bacterially 
expressed domain A of Xenopus Lef/Tcf proteins fused to GST were incubated with 
in vitro-translated 35S-labelled MBP1 and bound proteins were separated on an SDS 
PAGE gel. Following exposure of gel to phosphoimaging plate, phosphoimager 
results revealed that mMBP1 has a molecular weight of 49 kD corresponding to the 
predicted molecular weight. Binding of 35S-MBP1 to GST control was reduced to 
traces, while weak binding was observed to XLef-1. Strong binding was detected for 
XTcf-3 and XTcf-4 (Fig. 35). A faint band is also observed for MBP1 binding to GST 
but might correspond to a higher amount of GST input as observed on the 
Coomassie-stained gel. 
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Fig. 35: MBP1 binds to Xenopus Tcf-3 and Tcf-4 but w
Lef/Tcf-GST fusions of domain A were immobilized on gl
with in vitro translated 35S-labeled mMBP1. Bound protein
gel. The autoradiograph (upper panel) shows that bindi
MBP∗) to GST control was faint (lane 1), binding of XLef
binding was observed to XTcf-3( lane 3) and XTcf-4 (lane4
gel stained with Coomassie to demonstrate equal loading. 
 
 
Using degenerate primers, the Xenopus homologue
Xenopus tadpole stage cDNA library. It comprises of a
900 bp (Fig. 36). The deduced amino acid sequen
weight of the XMBP1 is about 35 kD. Alignment omMBP1∗      1          2         3           4massie-stained 
oradiograph 29eakly to Lef-1. A) Recombinant 
utathione sepharose and incubated 
s were resolved on an SDS PAGE 
ng of 35S-MBP1 (represented by 
-1 was weak (lane 2) while strong 
). The lower panel shows the same 
 of MBP1 was isolated from 
n open reading frame of about 
ce reveals that the molecular 
f the protein sequence of the 
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isolated XMBP1 with the murine orthologue revealed 80% amino acid identity (Fig. 
37). The XMBP1 sequence however lacked the 5´ leader sequence.  
 
            M   L   G   S   Y   H   C   K   C   P   E   G   Y  
TCG CTG CTC CGG CCG CCA TGG CCG CGG GAT TGG CCT CTC GAG ATG CTT GGT AGC TAT CAC TGC AAG TGT CCA GAG GGC TAC
  
 R   K   I   G   N   E   C   V   D   I   D   E   C   R   Y   R   Y   C   Q   H   R   C   V   N   Y   P   G 
AGG AAG ATT GGG AAT GAG TGT GTA GAC ATA GAT GAG TGC CGA TAT CGA TAC TGC CAA CAC CGA TGC GTT AAC TAC CCA GGT 
 
 S   F   V   C   Q   C   E   P   G   F   Q   L   A   S   N   N   R   S   C   V   D   V   N   E   C   S   M 
TCT TTT GTT TGT CAG TGC GAG CCT GGA TTT CAG CTG GCA TCA AAT AAC CGC TCC TGT GTG GAT GTT AAT GAG TGC TCA ATG 
  
 G   T   P   C   Q   Q   R   C   Y   N   T   Y   G   T   F   L   C   R   C   N   Q   G   Y   E   L   S   H 
GGC ACT CCC TGC CAG CAA AGG TGT TAT AAC ACC TAT GGG ACA TTC CTG TGC CGC TGC AAT CAG GGC TAC GAA CTG AGC CAT 
 
 D   G   Y   T   C   T   D   I   D   E   C   S   Y   S   S   Y   L   C   Q   H   Q   C   V   N   E   P   G 
GAT GGA TAT ACC TGC ACT GAT ATT GAT GAG TGC AGT TAT TCC AGT TAC CTT TGC CAG CAT CAG TGT GTG AAT GAG CCC GGA 
 
 S   F   S   C   S   C   P   E   G   Y   Q   L   L   G   T   R   L   C   Q   D   I   N   E   C   E   L   G 
AGC TTC TCC TGT AGT TGT CCC GAA GGA TAC CAG CTT TTA GGC ACC CGA CTG TGC CAA GAT ATC AAT GAG TGT GAA CTT GGG 
 
 T   H   S   C   S   E   Q   Q   T   C   V   N   F   H   G   G   Y   Q   C   V   E   K   N   R   C   Q   E 
ACC CAT AGC TGC TCA GAA CAG CAG ACC TGT GTC AAC TTT CAT GGG GGT TAC CAA TGC GTG GAA AAG AAT CGC TGC CAG GAA 
 
 P   F   I   Q   V   S   E   N   R   C   M   C   P   G   T   N   P   L   C   H   D   E   P   G   S   V   V 
CCT TTT ATC CAA GTG TCT GAA AAC CGC TGT ATG TGT CCT GGG ACC AAT CCC CTG TGC CAT GAT GAA CCG GGC TCT GTG GTG 
 
 Y   R   Y   M   S   I   T   S   D   R   S   V   P   S   E   I   F   Q   I   Q   A   T   S   V   Y   P   G 
TAT AGA TAC ATG AGC ATC ACA TCA GAC AGA AGT GTG CCC TCC GAA ATA TTC CAG ATA CAG GCA ACC AGC GTC TAC CCT GGA 
 
 A   Y   N   I   F   Q   I   R   S   G   N   E   Q   G   E   F   F   I   R   Q   I   N   N   L   T   A   M 
GCT TAT AAC ATA TTC CAA ATC CGC TCA GGA AAT GAG CAA GGA GAG TTC TTC ATC AGG CAA ATC AAC AAC CTC ACA GCT ATG 
 
 L   V   L   A   R   P   V   I   G   P   K   E   Y   V   L   D   L   E   M   L   T   T   N   S   L   L   S 
CTT GTC CTG GCC CGC CCT GTC ATT GGC CCC AAA GAG TAT GTA CTG GAT CTG GAA ATG CTA ACC ACC AAT TCT CTG CTG AGT 
 
 Y   R   S   S   S   V   L   R   L   T   V   F   V   G   A   H   S   F 
TAC CGC TCC AGC TCT GTG CTT AGA CTC ACC GTG TTT GTG GGA GCT CAT TCC TTC TAG CTC GAG AGG CCA ATC ACT AGT GCG 
                                                                      
GCC GCC TGC AGG TCG ACC ATA TGG GAG AGC TCC CAA CGC GTG GAG CAA 
 
Fig. 36: Xenopus MBP1 DNA has an open reading frame of 900 bp.  The deduced amino 
acid sequence ofMBP1 protein is indicated. 
 
 
mMBP-1 MLPFASCLPG SLLLWAFLLL LLGAASPQDP EEPDSYTECT DGYEWDADSQ HCRDVNECLT      
                                                                               
mMBP-1 IPEACKGEMK CINHYGGYLC LPRSAAVISD LHGEGPPPPA AHAQQPNPCP QGYEPDEQES     
 
mMBP-1 CVDVDECTQA LHDCRPSQDC HNLPGSYQCT CPDGYRKIGP ECVDIDECRY RYCQHRCVNL     
XMBP-1                         MLGSYHCK CPEGYRKIGN ECVDIDECRY RYCQHRCVNY      
      
mMBP-1 PGSFRCQCEP GFQLGPNNRS CVDVNECDMG APCEQRCFNS YGTFLCRCNQ GYELHRDGFS     
XMBP-1 PGSFVCQCEP GFQLASNNRS CVDVNECSMG TPCQQRCYNT YGTFLCRCNQ GYELSHDGYT      
 
mMBP-1 CSDIDECGYS SYLCQYRCVN EPGRFSCHCP QGYQLLATRL CQDIDECETG AHQCSEAQTC     
XMBP-1 CTDIDECSYS SYLCQHQCVN EPGSFSCSCP EGYQLLGTRL CQDINECELG THSCSEQQTC     
 
mMBP-1 VNFHGGYRCV DTNRCVEPYV QVSDNRCLCP ASNPLCREQP SSIVHRYMSI TSERSVPADV     
XMBP-1 VNFHGGYQCV EKNRCQEPFI QVSENRCMCP GTNPLCHDEP GSVVYRYMSI TSDRSVPSEI     
 
mMBP-1 FQIQATSVYP GAYNAFQIRS GNTQGDFYIR QINNVSAMLV LARPVTGPRE YVLDLEMVTM     
XMBP-1 FQIQATSVYP GAYNIFQIRS GNEQGEFFIR QINNLTAMLV LARPVIGPKE YVLDLEMLTT     
 
mMBP-1 NSLMSYRASS VLRLTVFVGA YTF                                             
XMBP-1 NSLLSYRSSS VLRLTVFVGA HSF                                             
 
Fig. 37: Protein alignment of XMBP1 protein sequence with its murine orthologue reveals 
about 80% identity. This sequence however lacks the 5´ leader sequence. 
5.12.2    MBP1 activates Wnt/β-catenin target promoters 
 
To study the influence of the MBP1 interaction with Lef/Tcfs, human epithelial kidney 
cells (h293) cells were co-transfected with siamois, CMV-β-galactosidase (for 
normalization), Lef/Tcf and MBP1constructs. Reporter gene assay results reveal that 
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in the absence of MBP1, XLef-1, XLef-1+Exon and XTcf4-C activate the siamois 
promoter while Tcf-4A and XTcf-3 has little effect on promoter activity (Fig. 38A).   
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mutated siamois promoter which lacks the Lef/Tcf binding sites was neither regulated 
by MBP1 not XLef-1+Exon (Fig. 38B).     
Similar results were obtained with the fibronectin promoter. In the absence of MBP1, 
only XLef-1 and XTcf-4C activate the promoter but in the presence of MBP1, there is 
a general enhancement of the promoter in the absence as well as in the presence of 
Lef/Tcfs (Fig. 39).  
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6.     Discussion 
 
6.1     Identification of putative binding partners of the XLef/Tcfs 
 
The functional diversity between the different XLef/Tcf family members (Gradl et al., 
2002, Roel et al., 2002) implies that the individual family members recruit specific 
binding partners which lead to their characteristic functions. Analysis of various XTcf 
mutants and XLef/Tcf chimeric constructs indicate that the region responsible for the 
individual characteristics is the less conserved and poorly characterised region (core 
region) spanning from the β-catenin binding site to the HMG box (Gradl et al., 2002).  
Putative Lef/Tcf binding partners of the Lef/Tcfs were identified using this core region 
as bait in a two-hybrid. GST pull-down assays to confirm the yeast two-hybrid results 
revealed that Hydrogen peroxide-inducible clone 5 (Hic-5) and Mutant-binding 
protein-1 (MBP-1) were true positives while Melanoma-associated antigen D1 
(MAGED1 or DLXIN) and Toll-interacting protein (TOLLIP) still need to be verified. 
TOLLIP is reported to interact with Toll-like receptors thereby blocking the Toll-Like 
receptor signalling pathway (Zhang and Ghosh, 2002). This pathway is responsible 
for accumulation of tumour necrosis factor (TNF)-α and interleukin (IL)-β in 
inflammatory processes (Moynagh, 2003). The binding of TOLLIP to Tcf-3 and Tcf-4 
might reveal a cross-talk between Wnt/β-catenin signalling and Toll-like receptor 
signalling pathways in which TOLLIP serves as an adaptor protein. This might 
therefore link the Wnt/β-catenin signalling to the modulation of inflammatory 
processes. 
Like β-catenin, the stability of DLXIN-1 is under the control of an ubiquitin-dependent 
degradation pathway (Masuda et al., 2001). It is a transcriptional regulator of DLXIN-
5, which is involved in osteoblast formation. Dlx5 is a Bone morphogenic protein 
(BMP)-inducible gene (Miyama et al., 1999) expressed in most developing skeletal 
elements. It is induced during the process of bone development and post-fracture 
healing (Yaoita et al., 1999). The interaction of DLXIN-1 with Tcf-3 and Tcf-4 might 
suggest an additional level of cross-talk between the BMP pathway and the Wnt/β-
catenin signalling. However, this cross-talk needs to be verified. 
The fact that none of the known Lef/Tcf binding partners was got in the yeast two-
hybrid screen is not unexpected since most of the known Lef/Tcf binding partners 
bind to the β-catenin binding site or the HMG box. The region of Lef/Tcfs used as bait 
in the screen was the core region of these transcription factors. Groucho which binds 
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to this core domain of Lef/Tcfs (Fig. 40) is a strong repressor (Brantjes et al., 2002) 
and might have repressed the VP16 activation domain in the library vector such that 
target gene activation is impossible. Hence, Groucho is not necessarily expected to 
be got from the screen.  
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Fig. 40: In addition to Groucho, ALY and Nemo-like kinase (NLK), Hic-5 and MBP1 bind 
to the core domain of Lef/Tcfs. Hic-5 binds to the alternatively spliced activating and 
conserved Exon of XTcf-3 and XTcf-4. MBP1 binds to the same Exon as well as well as to 
the poorly characterised domain A of all XLef/Tcfs. All other known binding partners bind 
outside the core region.    
  
Another protein, ALY, binds specifically to part of the core domain (Fig. 40) 
corresponding to the context dependent activation domain (CAD) of Lef-1 (Bruhn et 
al., 1997). This CAD is absent in Tcf-3 and Tcf-4. Since only XTcf-3 and XTcf-4 and 
not XLef-1 was used in the screen, the isolation of ALY was not expected. The 
Nemo-like kinase (NLK) has also been described to bind and phosphorylate Lef/Tcfs 
at their core domain (Ishitani et al., 2003) (Fig. 40). However, considering the 
transient nature of kinase binding the chance of isolating NLK is very low. 
All new identified potential binding partners did not discriminate in binding between 
XTcf-3 and XTcf-4 in GST pull-down assays thereby confirming the specificity of the 
bait-prey interaction observed in the yeast two-hybrid screen. This inability to 
discriminate between XTcf-3 and XTcf-4 also implies that the binding site does not 
represent the XTcf-4-specific region comprised of 20 amino acids located at a 
position spanning from aa127- aa147 (König et al., 2000). However, differences in Lef-1 
and Tcf-3/-4 binding was observed for Hic-5 and to a lesser extent also for MBP1.  
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6.1.1      Hic-5, A Novel Repressor of Lef/Tcf-Driven Transcription 
 
Hydrogen peroxide induced clone 5 (Hic-5) is a dual location protein found both at 
focal adhesion sites and in the nucleus (Shibanuma et al., 2003). It is a LIM domain 
protein and together with leupaxin, paxB and paxillin (Lipsky et al., 1998) forms a 
subfamily of type 3 LIM proteins. In addition to having four contiguous LIM domains in 
their C-terminal half, they have common LD motives in the N-terminal half (Brown et 
al., 1998). Both the LD motives and LIM domains potentially serve as an interface for 
interactions with other proteins (Dawid et al., 1995) or with DNA (Nishita et al., 2000).  
Because interaction between the mouse Hic-5 and the Xenopus Lef/Tcfs could be 
artificial as a result of differences in species, a Xenopus ortholoque of Hic-5 was 
isolated and used with the Xenopus Lef/Tcfs in GST pull-down assays.  
 
6.1.1.1     Hic-5 binds to XTcf-3 and XTcf-4 but not to XLef-1 
 
Hic-5 was identified to bind preferentially to XTcf-3 and XTcf-4 but not to XLef-1. This 
subtype-specific binding suggests that Hic-5 might regulate XTcf but not XLef-1 
function. The binding site of Hic-5 to XTcf-3 and XTcf-4 was mapped to the 
conserved and alternatively spliced activating exon which is absent in all XLef 
variants reported so far (Levanon et al., 1998, Pukrop et al., 2001). This Exon shares 
70% amino acid identity between mLef-1 and XTcf-3 and XTcf-4. The conserved 
nature of this Exon indicates to a common function and a common set of binding 
partners.  
The Hic-5 binding domain in XTcfs overlaps with the Groucho-binding domain, which 
has been shown to span the region between the β-catenin binding site and the HMG-
box (Brantjes et al., 2001). However, the binding domains for Groucho and Hic-5 are 
not identical because, despite the presence of the Groucho binding site in all 
Xenopus  Lef/Tcfs (Pukrop et al., 2001) only XTcf-3 and XTcf-4 could bind Hic-5.  
The binding region in Hic-5 was mapped to the Lim domain-containing C-terminus 
although this binding appeared weak. These LIM domains in Hic-5 have been found 
to be responsible for binding to a multitude of proteins as well as nucleic acids. 
Spectroscopic analysis demonstrates that the LIM domains in general define a 
specific zinc binding structure in which zinc coordination renders it functional in 
binding to other proteins and DNA (Michelsen et al., 1993). The fact that mouse and 
Xenopus Hic-5 bound to all human and murine and Xenopus Lef/Tcfs tested 
indicates that this binding is conserved within and across the vertebrate species.  
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The binding of Hic-5 to Lef/Tcfs might indicate that it is an adaptor protein mediating 
the cross-talk between different signalling cascades. Because Hic-5 binds both 
Lef/Tcfs (present study) and smad 3 (Shibanuma et al., 2003) it might likely also link 
the transforming growth factor (TGF)-β and Wnt/β-catenin signalling pathways. Since 
Hic-5 is also known to bind to and activate steroid receptors (Fujimoto et al., 1999) its 
binding to Lef/Tcfs couples the Wnt/β-catenin signalling with steroid signalling. The 
localization of Hic-5 at focal contacts and the binding to the focal adhesion kinase 
(FAK) (Nishiya et al., 2002) might indicate that in addition to integrin-linked kinase 
(ILK) Hic-5 might regulate Wnt/β-catenin signalling and thus provide an additional 
mechanism that integrates integrin-mediated outside-in signalling with Wnt/β-catenin 
signalling.  
 
6.1.1.2      Hic-5 represses Wnt/β-catenin target genes 
 
Although Hic-5 has been described as an activator of androgen receptors (Fujimoto 
et al., 1999) it turned out in this study that the interaction with Lef/Tcfs results into a 
repressive complex. The repressive nature of this complex was not only observed in 
reporter gene assays where target gene promoters such as TOPFlash and Xenopus 
fibronectin were down regulated but was also observed in injected Xenopus embryos 
where transcription of Lef/Tcf target genes such as siamois and Xnr3 were 
repressed. The fact that this repression was demonstrated not only with Xenopus 
Tcfs but also with murine and human Lef/Tcfs indicates to what extent this regulatory 
step is conserved in vertebrates.  
Hic-5 was mapped to bind to the conserved Exon previously described to represent 
the activating motifs of the Lef/Tcfs (Gradl et al., 2002). Although the mode of 
activation via the conserved Exon is still unknown, the specific binding of Hic-5 to this 
Exon constitutes a novel repressive mechanism of Lef/Tcf function. The presence of 
this Exon in Xenopus Tcfs but not in XLef-1 explains the importance of this 
regulation: it favours Hic-5-mediated repression of all XTcf-driven genes and avoids 
inappropriate repression of XLef-1. Numerous experiments have revealed that 
Lef/Tcfs do not only function as activators of transcription when activated by Wntβ-
catenin signals. They have been described to actively interact with co-repressors to 
inhibit target gene expression thereby preventing inappropriate Wnt/β-catenin 
signalling. Many mechanisms have been proposed on how this interaction inhibits 
target genes. Alteration of the chromatin structure has been described for interactions 
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between Lef/Tcfs and Groucho (Brantjes et al., 2002) or CtBP (Brannon et al., 1999). 
Lef/Tcf function is also inhibited by masking of their conserved domains by proteins 
such as CBP (Waltzer and Bienz, 1998), HBP1 (Sampson et al., 2001), PIAS1 
(Sachdev et al., 2000) and steroid receptors (Amir et al., 2003) while phosphorylation 
of Lef/Tcfs by NLK constitute an unusual means by which Wnt/β-catenin signalling is 
inhibited (Ishitani et al., 2003). Whether Hic-5 binding to the activating Exon uses one 
of these mechanisms or an alternative mode to inhibit Lef/Tcf-induced transcription 
remains a subject of controversy.  
XHic-5 has been found to display both timely and spatially restricted expression 
patterns. From RT-PCR results, XHic-5 is maternally expressed, down regulated at 
blastula, peaks at gastrula and continues to be expressed at low levels in the neurula 
and tail bud stages (Stephanie van Venrooy, Diploma thesis, 2004). In situ 
hybridisation reveals that at the blastula stage XHic-5 is expressed in the animal 
hemisphere, at neurula stage it is expressed at the dorsal side and at later stages its 
expression is observed around the eye, in the branchial arch, somites and in the 
pituitary gland (Martin Ritthaler, Diploma thesis, 2005). Despite the evidence from the 
present study that XHic-5 binds to the XTcfs, only partial overlapping patterns of 
expression of both XHic-5 and some of the Lef/Tcf transcription factors were 
observed in Xenopus. Like XHic-5, XTcf-3 is expressed maternally and transcripts 
have also been detected around the eyes and the branchial arch. This co-expression 
might suggest their involvement in the regulation of the canonical Wnt signalling 
pathway in these organs.  
Expression of Tcf-4 in the mouse is detected in the crypts where it plays a role in the 
maintenance of stem cells (Korinek et al., 1998) and in the maturation of Paneth cells 
in the mouse intestine (vanEs et al., 2005). On the contrary, Hic-5 and its interaction 
partner, the orphan nuclear receptor, peroxisome proliferator-activated receptor 
(PPAR) gamma (PPARγ), induce an epithelial program in the mouse intestinal 
microvilli (Drori et al., 2005). Whereas PPARγ expression is restricted to the 
microvilli, Tcf-4 expression is uniquely in the crypts while Hic-5 expression extends 
from the crypts to the microvilli. These overlapping patterns between mHic-5 and Tcf-
4 on one hand and mHic-5 and PPARγ on the other hand give evidence that the 
interaction of Hic-5 with PPARγ (Drori et al., 2005) and Lef/Tcfs (present study) is 
involved in the decision whether the intestinal cells continue to proliferate (high Tcf-4, 
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low Hic-5, low PPARγ) or whether they start to differentiate to epithelial cells (Low 
Tcf-4, high Hic-5, high PPARγ). 
Although XHic-5 was found to bind to XTcf-4, during development XHic-5 and XTcf-4 
are not co-expressed in the developing brain. In both mouse and Xenopus, Tcf-4 is 
expressed in the developing midbrain (König et al., 2000, Barker and Clevers, 2000) 
but XHic-5 expression has not been detected in this region (Yuminamochia et al., 
2003, Martin Ritthaler, Diploma thesis, 2005). 
 
6.1.2     Lef/Tcfs repress Hic-5-induced steroid receptor target gene activation 
 
Hic-5 has been described as a co-activator of a subset of steroid receptors (SRs). It 
binds to and activates androgen receptors (ARs) (Fujimoto et al., 1999) and 
glucocorticoid receptors (GRs), (Yang et al, 2000). Although it does not directly bind 
to estrogen receptors (ERs), it potentiates ER activity in the presence of a glutamate 
receptor interacting protein (GRIP)-1 (Yang et al., 2000). SRs belong to the family of 
ligand-activated Zinc-finger transcription factors and consist of an N-terminal 
transactivation domain, two zinc-fingers and a hormone-binding site. Upon ligand 
binding, the steroid receptor changes its conformation, which reduces the binding 
affinity of inhibitors (e.g. hsp90). After dimerization it enters the nucleus and activates 
target genes (Roy et al. 2001).   
Consistent with the fact that Hic-5 binds to the Lef/Tcf transcription factors resulting 
into a repressive complex, Hic-5-induced SR activation was repressed in the 
presence of Lef/Tcfs. This repression was also mediated through recruitment of Hic-5 
to the conserved Exon of Lef/Tcfs since XLef-1 lacking this Exon had no effect on 
Hic-5-mediated SR activation. Interestingly, all other tested Lef/Tcf family members 
from mouse and human species possessing the conserved Exon down-regulated 
Hic-5-induced SR activation indicating to a highly conserved mechanism in 
vertebrates. This repression was also observed at the level of SR target gene 
activation where glucocorticoid target genes, p21cip1 and p27kip1 were up-regulated by 
Hic-5 and this up-regulation was repressed by co-transfection of Tcf-4. In this study 
Hic-5 binding to the Lef/Tcfs was preferentially through their LIM domains suggesting 
that this repression is mediated through the LIM domains of Hic-5. LIM domains of 
Hic-5 interact with SRs. The fact that deletion of these domains abolishes activation 
of ARs (Fujimoto et al., 1999) and GRs (Yang et al, 2000) points to the indispensable 
role they play in Hic-5-induced SR activation. The binding of the LIM domains of Hic-
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5 to the Lef/Tcfs may mask and make them unavailable for SR activation. The 
interaction between Hic-5 and Lef/Tcfs also exposes a novel mechanism by which 
the Wnt/β-catenin signalling regulates SR signalling.  
Tcf-4 has been described to pay a repressive role in signalling through AR in CV1 
epithelial cells (Amir et al. 2003) and ER in rat mammary cells (Eltanini et al., 2001). 
Although this repression has been found to be mediated by direct interaction 
between these SRs and Tcf-4, the present study which reveals a physical interaction 
between Hic-5 and the Lef/Tcfs adds a further mechanism to the present view of the 
cross-talk between SR signalling and Wnt/β-catenin signalling. The recruitment of 
Hic-5 by the Lef/Tcfs might represent a means by which the Wnt/β-catenin pathway 
represses and thus controls steroid receptor signalling.  
 
6.1.3     MBP1, a Novel Activator of Wnt/β-catenin target genes 
 
MBP1 (mutant p53 binding protein)-1 or fibulin-4 belongs to a versatile family of 
glycoproteins known as fibulins.  They are characterised by an epidermal growth 
factor (EGF)-like repeat at the N-terminus and a fibulin-type module in their C-
terminus (Argraves et al., 1989). Although fibulins are described as extracelluar 
matrix proteins, a cytosolic/nuclear role has been ascribed to MBP1. It binds to an 
oncogenic mutant of p53 protein, preferentially to an Arg175His mutant and promotes 
neoplastic transformation and tumour growth (Gallagher et al., 1998).  
 
6.1.3.1     Mouse MBP1 binds to XLef-1, XTcf-4 and XTcf-3 
 
Mouse MBP1 was identified to bind to XTcf-3 and XTcf-4 and to XLef-1. Whereas  
strong binding to core domains of XTcf-3 and XTcf-4 was observed, the binding to 
XLef-1 was weak. Since the major difference between these transcription factors is 
the absence of the alternatively spliced activating Exon in XLef-1, this Exon alone 
might not account for the difference in affinity of Lef/Tcfs for binding mMBP1. The fact 
that similar results were obtained in GST pull-down assays with domain A (region 
between the β-catenin-binding site and the left flanking motive of the activating Exon) 
of XLef/Tcfs and mMBP1 suggests that this domain might collaborate with the Exon 
in binding to MBP1. 
The identification of MBP1 as a binding partner of Lef/Tcfs is tempting to implicate 
MBP1 in p53 signalling. P53 has been found to activate glycogen synthase kinase 
(GSK)-3β thereby reducing β-catenin levels and consequently limiting Lef/Tcf-
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induced target gene activation. However, the preferential binding of MBP1 to mutated 
forms and not the wild type form of p53 (Gallagher et al., 1998) suggests that its 
endogenous function might not be the control of p53/β-catenin/Lef/Tcf signalling. The 
interaction of MBP1 and Lef/Tcfs might instead suggest a cross-talk between the 
Wnt/β-catenin and mutated p53 signalling in neoplastic transformation and tumour 
growth. This crosstalk could be exposed by either investigating the influence of MBP1 
and Lef/Tcfs on mutant p53 target gene promoters in reporter gene assays or 
knocking out MBP1 in cancer cell lines to observe if the two oncogenic pathways 
(mutant p53 and the Wnt/β-catenin signalling) share a common binding partner.  
 
6.1.3.2      Mouse MBP1 activates Wnt target gene promoters 
 
In contrast to Hic-5, MBP1 was observed to enhance the Lef/Tcf-induced  
transcription. This enhancement was not specific to any Lef/Tcf family member 
suggesting that MBP1 is a general Lef/Tcf co-activator and might not contribute to the 
functional specificity observed in Lef/Tcfs. This indiscriminate activation of Lef/Tcfs by 
MBP1 is similar to that of other activators that synergistically enhance Lef/Tcf 
transcriptional potential such as the CREB-binding protein (CBP) and the smads. The 
mechanisms of Lef/Tcf activation involve modelling of the chromatin structure by CBP 
(Takemaru and Moon, 2000) and recruitment of co-activators to target promoters for 
smads (Deynck et al., 1998). The mechanism by which MBP1 activates the Lef/Tcf 
target promoters is not yet known. It is speculative that MBP1 might either use the 
same mechanism like CBP and smads or an alternate mechanism to activate the 
Lef/Tcfs.  
Activation of Wnt/β-catenin target gene promoters (siamois and fibronectin) by MBP1 
might suggest that MBP1 required in endogenous axis specification. This is excluded 
because in Xenopus, XMBP1 expression starts at the end of gastrulation and 
increases in the neural tissue (D. Gradl, personal communication). β-catenin/Lef/Tcf-
induced endogenous axis specification however takes place before gastrulation.  
Instead MBP1 might be involved in later developmental processes such as Wnt-
triggered neural patterning. XMBP1 expression is localized in the early neural tissue 
(D. Gradl, Personal communication) overlapping with the expression pattern of XTcf-
1 (Roel et al., 2003), XLef-1, and XTcf-3 (Molenaar et al., 1998) thereby indicating 
that it might play a role in Wnt/β-catenin-regulated patterning of the neuroectoderm. If 
this is the case then MBP1 should be involved in posteriorizing the neural tissue 
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which is mediated by Wnt proteins. Expression of XWnt-3a has been found to induce 
posterior and suppresses anterior neural marker genes in neuralized animal explants 
(McGrew et al., 1995). Conversely, in vivo blockage of Wnt ligands by expression of 
a dominant negative Xwnt-8 results in loss of posterior neural fates  (McGrew et al., 
1997). Overexpression studies and morpholino knockdown of XMBP1 might therefore 
be necessary to investigate its precise role in neural patterning. A Xenopus 
homologue of mouse MBP1 has been isolated from the Xenopus tadpole stage 
library. Although the 5´ leader sequence is missing in the isolated XMBP1, the 
deduced amino acid sequence shows that it is about 80% identical to the mouse 
orthologue therefore suggesting a conservation in function between these fibulins. 
However, the absence of a leader sequence suggests that further screening is 
necessary to verify if a longer clone exists for XMBP1 or not.  
In summary, MBP1 binds to part of the core region and the alternatively spliced 
conserved and activating Exon. This binding does not only reveal that the two 
oncogenic pathways, Wnt/β-catenin and mutant p53 signalling, might share a 
common co-activator but also that MBP1 might be involved in Wnt/β-catenin 
mediated neural patterning.  
 
6.2      Proposed model by which recruitment of Hic-5 and MBP1 by Lef/Tcfs 
           establishes cross-talks with other signalling pathways 
 
In addition to cross talks between the Delta/notch, p53, TGF-β, steroid receptors and 
Wnt/β-catenin signalling, the recruitment of Hic-5 and MBP1 exposes novel cross-
talks between the Wnt/β-catenin ant other signalling pathways which suggests that 
communication could be bidirectional. Hic-5 establishes a cross talk between the 
Wnt/β-catenin signalling and steroid signalling pathways. In this cross-talk, the Wnt/β-
catenin represses steroid signalling through the recruitment of the steroid receptor 
co-activator, Hic-5 by the Lef/Tcfs. Reciprocally, steroid receptors are shown to 
regulate Wnt/β-catenin signalling (Smith and Frankel, 2005) thereby suggesting a 
complex cross- regulatory network between these pathways (Fig. 41). 
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Fig. 41: Hic-5 and MP1 bind to Lef/Tcfs and establishes novel cross-talks between Wnt/β-
catenin signalling and other signalling pathways. In addition to cross talks established 
between the Wnt/β-catenin pathway and the Delta/Notch, p53, Transforming growth factor 
(TGF)-β and steroid receptors (SR), Hic-5 binding to Lef/Tcfs establishes a novel link 
between Wnt/β-catenin signalling and steroid signalling through SRs. MBP1 binding to 
Lef/Tcfs might also establish a co-operation between Wnt/β-catenin signalling and mutant 
p53 signalling. These two prominent oncogenic pathways might share the same co-activator, 
MBP1. Red arrows correspond to novel signalling pathways.The question mark coreespond to 
a pathway that needs further investigation. 
 
MBP1 also establishes a cross-talk between the Wnt/β-catenin signalling and the 
mutant p53 signalling through the mutant p53 suggesting that these two oncogenic 
pathways might use the same co-activator. (Fig. 41).  
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7.    Summary 
As nuclear transducers of the Wnt/β-catenin signalling cascade, Lef/Tcf transcription 
factors are involved in many important developmental decisions and in the 
development of cancer. The four vertebrate members: Tcf-1, Tcf-3, Tcf-4 and Lef-1 
are characterized by a highly conserved N-terminal β-catenin binding site and an 
even more conserved DNA-binding site, the HMG-box. The region in between these 
two conserved domains is less conserved and is thought to provide the individual 
Lef/Tcfs with their characteristic functional properties. Although many binding 
partners of Lef/Tcfs have been isolated over the past years, the molecular nature of 
the functional diversity of Lef/Tcfs is not yet known. In order to identify novel Lef/Tcf-
subtype specific binding partners, a mouse embryonic day 10 yeast-two hybrid library 
was screened using the core-region of XTcf-3 and XTf-4 as bait. Among the isolated 
clones, Hic-5 and MBP-1 were confirmed in GST-pulldown experiments and further 
characterized.  
The Xenopus homologue of Hic-5 was isolated and the predicted protein revealed an 
overall identity of 40 % to its murine and human orthologues. Protein binding assays 
revealed that the interaction between Hic-5 and Lef/Tcfs is conserved in vertebrates. 
Hic-5 binds via its Lim-domains containing C-terminus to an alternatively spliced 
Exon in Lef/Tcfs, resulting in a complex that represses both Tcf-driven transcription 
and Hic-5 mediated steroid receptor activation. Thus, Hic-5 is a novel Lef/Tcf-subtype 
specific binding partner that mediates the dialogue between Wnt/β-catenin and 
steroid signalling. 
The Xenopus homologue of MBP1 was isolated and the predicted protein revealed 
an overall identity of 80% to its murine orthologue. The most obvious difference 
between the Xenopus and murine orthologues is, that XMBP1 is 142 amino acids 
shorter at the N-terminus. This might indicate that the isolated cDNA does not 
encode the entire open reading frame. 
In contrast to Hic-5, MBP1 activates Lef/Tcf-sensitive promoters. MBP1 is reported to 
bind to mutated p53 leading to an enhancement of its activity in neoplastic 
transformation and tumour growth. It is therefore likely that the two most prominent 
oncogenic pathways (Wnt/β-catenin and mutated p53 signalling pathways) do not 
only share the same co-activator (MBP1) but also communicate through MBP1. 
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8.    Zusammenfassung 
Als nukleäre Mediatoren der Wnt/β-catenin Signalkaskade sind die 
Transkriptionsfaktoren der Lef/Tcf Familie an zahlreichen entwicklungsbiologischen 
Prozessen und in der Entstehung einiger Krebsarten entscheidend beteiligt. Die vier 
Vertebraten-Vertreter der Lef/Tcfs zeichnen sich durch eine hoch konservierte β-
catenin-Bindestelle am N-Terminus und eine noch höher konservierte DNA-
Bindedomäne, die HMG-box, aus. Die Region zwischen diesen hoch konservierten 
Bereichen ist weniger konserviert und stattet die einzelnen Lef/Tcfs mit ihren 
individuellen Charakteristika aus. Obwohl in den letzten Jahren zahlreiche 
Interaktionspartner identifiziert wurden, ist der molekulare Mechanismus, welcher der 
funktionalen Diversität der Lef/Tcfs zugrunde liegt, noch weitgehend unbekannt. Um 
neue Tcf-Subtyp spezifische Interaktionspartner zu identifizieren wurde im Hefe „two-
hybrid“ System eine murine embryonale Bibliothek mit der zentralen Region von 
XTcf-3 und -4 durchgemustert. Von den dabei erhaltenen putativen neuen 
Interaktionpartnern ließen sich hydrogenperoxide inducible clone 5 (Hic-5) und 
mutant p53 binding protein (MBP1) in GST-pulldown Expermenten bestätigen. 
Das Xenopus Homologe zu Hic-5 wurde isoliert und ist auf Aminosäureebene zu 
40% identisch zu seinem murinen und humanem Orthologen. Protein-
Bindungstudien zeigen, dass in Vertebraten die Interaktion von Hic-5 und Lef/Tcfs 
konserviert ist. Hic-5 bindet mit seinem LIM-Domänen-enthaltenden C-Terminus an 
ein konserviertes, alternativ gespleißtes Exon der Lef/Tcfs. Dies resultiert in einem 
repressiven Komplex, der sowohl Tcf-abhängige Trankription unterdrückt, als auch 
die Hic-5 vermittelte Aktivierung von Steroidrezeptoren reprimiert. Somit wurde Hic-5 
als neuer Tcf-Subtyp-spezifischer Interaktionspartner identifiziert, der im Dialog 
zwischen der Wnt/β-Catenin Signalkaskade und Steroidrezeptoren involviert ist. 
Das Xenopus Homologe zu MBP1 wurde isoliert und ist auf Aminosäureebene zu 
80% identisch zu seinem murinen Orthologen. Auffallend ist, dass das Xenopus 
Homologe im N-Terminus um 142 Aminosäuren kürzer ist, was darauf hindeutet, 
dass die isolierte cDNA nicht den vollständigen offenen Leserahmen umfasst. Im 
Gegensatz zu Hic-5 aktiviert MBP1 Lef/Tcf sensitive Promotoren. Da MBP1 
bekannter weise mit mutiertem p53 interagiert und dadurch neoplastische 
Transformation und Tumorwachstum fördert und, wie in der vorliegenden Arbeit 
gezeigt, Lef/Tcf sensitive Promotoren aktiviert, scheint MBP1 als Mediator in zwei der 
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wichtigsten onkogenen Signalwegen beteiligt zu sein und könnte die Kommunikation 
zwischen diesen beiden Signalwegen regulieren.  
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List of abbreviations: 
 
AR   Androgen Receptor 
ARA-55  Androgen Receptor co Activator 
BMP   Bone Morphogenic Protein 
CAD    Context-dependent Activation Domain 
CBD   β-Catenin Binding Domain 
CBP   Cyclic AMP Receptor-Binding (CREB) Binding Proteins 
CtBP   C-terminal Binding Protein 
DBD    DNA-Binding Domain 
Dexa   Dexamethasone 
DHT    Dihydoroxytestosterone 
dNTP   Deoxyribonucleotides 
dTcf    Drosophila Tcf 
ER     Estrogen Receptor 
GR    Glucocorticoid Repressor 
GST    Glutathione-S-Transferase 
Hic-5    Hydrogen peroxide-Inducible Clone-5 
HMG   High Mobility Group 
Kbp   Kilo Base Pair 
KD   Kilo Dalton 
Lef    Lymphoid Enhancer Factor 
MALDI TOF Matrix-Assisted Laser- Desorption Ionization Time Of Flight 
MBP1   Mutant-p53-Binding Protein-1 
MMTV  Mouse Mammary Tumour Virus 
PPARγ  Peroxisome Proliferator-Activated Receptor (PPAR) gamma 
SR    Steroid Receptors  
Tcf   T-Cel Factor 
TGF   Transforming Growth Factor 
TOLLIP    Toll-Interacting Protein 
X. laevis  Xenopus laevis 
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